Reunió 20/10/2020
Lípid de referencia: PI 36:1
Resultats PI 36:1 Sa High vs Tumor High
Cluster Sample
Determinació Beta
Cluster gens
Correlació mòduls i fenotips
Gens drivers dels mòduls associats al fenotip
GO
Es mostren els 10 millors GO
| X | module | size | p.val | Bonf | nInTerm | GO.id | ont | term.name |
|---|---|---|---|---|---|---|---|---|
| 1 | antiquewhite2 | 44 | 5.9e-04 | 1.000 | 4 | GO:0004866 | MF | endopeptidase inhibitor activity |
| 2 | antiquewhite2 | 44 | 6.3e-04 | 1.000 | 2 | GO:0071004 | CC | U2-type prespliceosome |
| 3 | antiquewhite2 | 44 | 6.8e-04 | 1.000 | 4 | GO:0030414 | MF | peptidase inhibitor activity |
| 4 | antiquewhite2 | 44 | 2.0e-03 | 1.000 | 4 | GO:0010951 | BP | negative regulation of endopeptidase activity |
| 5 | antiquewhite2 | 44 | 2.3e-03 | 1.000 | 4 | GO:0010466 | BP | negative regulation of peptidase activity |
| 6 | antiquewhite2 | 44 | 2.9e-03 | 1.000 | 1 | GO:0072355 | BP | histone H3-T3 phosphorylation |
| 7 | antiquewhite2 | 44 | 2.9e-03 | 1.000 | 1 | GO:0097692 | BP | histone H3-K4 monomethylation |
| 8 | antiquewhite2 | 44 | 2.9e-03 | 1.000 | 1 | GO:1905221 | BP | positive regulation of platelet formation |
| 9 | antiquewhite2 | 44 | 2.9e-03 | 1.000 | 1 | GO:1905377 | BP | response to D-galactose |
| 10 | antiquewhite2 | 44 | 2.9e-03 | 1.000 | 1 | GO:1905396 | BP | cellular response to flavonoid |
| 11 | antiquewhite4 | 61 | 4.1e-04 | 1.000 | 4 | GO:0099055 | CC | integral component of postsynaptic membrane |
| 12 | antiquewhite4 | 61 | 5.7e-04 | 1.000 | 6 | GO:0045211 | CC | postsynaptic membrane |
| 13 | antiquewhite4 | 61 | 6.0e-04 | 1.000 | 2 | GO:0072178 | BP | nephric duct morphogenesis |
| 14 | antiquewhite4 | 61 | 6.1e-04 | 1.000 | 3 | GO:0090102 | BP | cochlea development |
| 15 | antiquewhite4 | 61 | 7.2e-04 | 1.000 | 6 | GO:0098978 | CC | glutamatergic synapse |
| 16 | antiquewhite4 | 61 | 7.5e-04 | 1.000 | 2 | GO:0048681 | BP | negative regulation of axon regeneration |
| 17 | antiquewhite4 | 61 | 9.1e-04 | 1.000 | 4 | GO:0099699 | CC | integral component of synaptic membrane |
| 18 | antiquewhite4 | 61 | 9.1e-04 | 1.000 | 2 | GO:0070571 | BP | negative regulation of neuron projection regeneration |
| 19 | antiquewhite4 | 61 | 9.1e-04 | 1.000 | 2 | GO:0030677 | CC | ribonuclease P complex |
| 20 | antiquewhite4 | 61 | 9.1e-04 | 1.000 | 2 | GO:0044233 | CC | Mitochondria-associated ER Membrane |
| 21 | bisque4 | 79 | 2.1e-04 | 1.000 | 3 | GO:0099637 | BP | neurotransmitter receptor transport |
| 22 | bisque4 | 79 | 3.8e-04 | 1.000 | 2 | GO:0098943 | BP | neurotransmitter receptor transport, postsynaptic endosome to lysosome |
| 23 | bisque4 | 79 | 4.3e-04 | 1.000 | 3 | GO:0061462 | BP | protein localization to lysosome |
| 24 | bisque4 | 79 | 5.4e-04 | 1.000 | 2 | GO:0072718 | BP | response to cisplatin |
| 25 | bisque4 | 79 | 5.4e-04 | 1.000 | 2 | GO:0035005 | MF | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
| 26 | bisque4 | 79 | 7.1e-04 | 1.000 | 2 | GO:0098970 | BP | postsynaptic neurotransmitter receptor diffusion trapping |
| 27 | bisque4 | 79 | 1.1e-03 | 1.000 | 2 | GO:0016303 | MF | 1-phosphatidylinositol-3-kinase activity |
| 28 | bisque4 | 79 | 1.4e-03 | 1.000 | 2 | GO:0035004 | MF | phosphatidylinositol 3-kinase activity |
| 29 | bisque4 | 79 | 1.5e-03 | 1.000 | 3 | GO:0097120 | BP | receptor localization to synapse |
| 30 | bisque4 | 79 | 2.0e-03 | 1.000 | 2 | GO:0036092 | BP | phosphatidylinositol-3-phosphate biosynthetic process |
| 31 | black | 543 | 6.0e-05 | 1.000 | 5 | GO:0048385 | BP | regulation of retinoic acid receptor signaling pathway |
| 32 | black | 543 | 4.3e-04 | 1.000 | 8 | GO:0042054 | MF | histone methyltransferase activity |
| 33 | black | 543 | 4.5e-04 | 1.000 | 5 | GO:0035357 | BP | peroxisome proliferator activated receptor signaling pathway |
| 34 | black | 543 | 6.4e-04 | 1.000 | 8 | GO:0046513 | BP | ceramide biosynthetic process |
| 35 | black | 543 | 6.5e-04 | 1.000 | 4 | GO:0035358 | BP | regulation of peroxisome proliferator activated receptor signaling pathway |
| 36 | black | 543 | 6.7e-04 | 1.000 | 24 | GO:0018205 | BP | peptidyl-lysine modification |
| 37 | black | 543 | 7.0e-04 | 1.000 | 9 | GO:0008276 | MF | protein methyltransferase activity |
| 38 | black | 543 | 8.5e-04 | 1.000 | 3 | GO:0001164 | MF | RNA polymerase I CORE element sequence-specific DNA binding |
| 39 | black | 543 | 9.1e-04 | 1.000 | 4 | GO:2000303 | BP | regulation of ceramide biosynthetic process |
| 40 | black | 543 | 1.2e-03 | 1.000 | 7 | GO:0016279 | MF | protein-lysine N-methyltransferase activity |
| 41 | blue | 925 | 2.8e-04 | 1.000 | 17 | GO:0007156 | BP | homophilic cell adhesion via plasma membrane adhesion molecules |
| 42 | blue | 925 | 5.2e-04 | 1.000 | 24 | GO:0098742 | BP | cell-cell adhesion via plasma-membrane adhesion molecules |
| 43 | blue | 925 | 6.7e-04 | 1.000 | 16 | GO:0016616 | MF | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor |
| 44 | blue | 925 | 7.2e-04 | 1.000 | 13 | GO:0009798 | BP | axis specification |
| 45 | blue | 925 | 8.7e-04 | 1.000 | 3 | GO:0072133 | BP | metanephric mesenchyme morphogenesis |
| 46 | blue | 925 | 1.4e-03 | 1.000 | 4 | GO:0098703 | BP | calcium ion import across plasma membrane |
| 47 | blue | 925 | 1.5e-03 | 1.000 | 17 | GO:0000187 | BP | activation of MAPK activity |
| 48 | blue | 925 | 1.6e-03 | 1.000 | 11 | GO:0036126 | CC | sperm flagellum |
| 49 | blue | 925 | 1.9e-03 | 1.000 | 50 | GO:0003006 | BP | developmental process involved in reproduction |
| 50 | blue | 925 | 2.0e-03 | 1.000 | 30 | GO:0032147 | BP | activation of protein kinase activity |
| 51 | blue2 | 55 | 1.2e-03 | 1.000 | 2 | GO:0055089 | BP | fatty acid homeostasis |
| 52 | blue2 | 55 | 1.4e-03 | 1.000 | 2 | GO:0010934 | BP | macrophage cytokine production |
| 53 | blue2 | 55 | 2.0e-03 | 1.000 | 2 | GO:0005719 | CC | nuclear euchromatin |
| 54 | blue2 | 55 | 2.2e-03 | 1.000 | 2 | GO:0035902 | BP | response to immobilization stress |
| 55 | blue2 | 55 | 2.2e-03 | 1.000 | 2 | GO:0036499 | BP | PERK-mediated unfolded protein response |
| 56 | blue2 | 55 | 2.2e-03 | 1.000 | 3 | GO:1903725 | BP | regulation of phospholipid metabolic process |
| 57 | blue2 | 55 | 2.4e-03 | 1.000 | 2 | GO:0006541 | BP | glutamine metabolic process |
| 58 | blue2 | 55 | 3.0e-03 | 1.000 | 14 | GO:0044281 | BP | small molecule metabolic process |
| 59 | blue2 | 55 | 3.5e-03 | 1.000 | 2 | GO:0032620 | BP | interleukin-17 production |
| 60 | blue2 | 55 | 3.6e-03 | 1.000 | 3 | GO:0032963 | BP | collagen metabolic process |
| 61 | blue4 | 29 | 1.1e-04 | 1.000 | 2 | GO:1990314 | BP | cellular response to insulin-like growth factor stimulus |
| 62 | blue4 | 29 | 5.8e-04 | 1.000 | 2 | GO:0043032 | BP | positive regulation of macrophage activation |
| 63 | blue4 | 29 | 1.3e-03 | 1.000 | 7 | GO:0005615 | CC | extracellular space |
| 64 | blue4 | 29 | 1.8e-03 | 1.000 | 1 | GO:0106028 | BP | neuron projection retraction |
| 65 | blue4 | 29 | 1.8e-03 | 1.000 | 1 | GO:1900450 | BP | negative regulation of glutamate receptor signaling pathway |
| 66 | blue4 | 29 | 1.8e-03 | 1.000 | 1 | GO:1904782 | BP | negative regulation of NMDA glutamate receptor activity |
| 67 | blue4 | 29 | 1.8e-03 | 1.000 | 1 | GO:0099631 | CC | postsynaptic endocytic zone cytoplasmic component |
| 68 | blue4 | 29 | 1.8e-03 | 1.000 | 1 | GO:0008459 | MF | chondroitin 6-sulfotransferase activity |
| 69 | blue4 | 29 | 2.2e-03 | 1.000 | 3 | GO:0005798 | CC | Golgi-associated vesicle |
| 70 | blue4 | 29 | 2.7e-03 | 1.000 | 2 | GO:0043030 | BP | regulation of macrophage activation |
| 71 | blueviolet | 29 | 1.3e-04 | 1.000 | 2 | GO:1990763 | MF | arrestin family protein binding |
| 72 | blueviolet | 29 | 7.1e-04 | 1.000 | 3 | GO:0034968 | BP | histone lysine methylation |
| 73 | blueviolet | 29 | 8.6e-04 | 1.000 | 3 | GO:0018022 | BP | peptidyl-lysine methylation |
| 74 | blueviolet | 29 | 1.1e-03 | 1.000 | 2 | GO:0035872 | BP | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| 75 | blueviolet | 29 | 1.1e-03 | 1.000 | 2 | GO:0070423 | BP | nucleotide-binding oligomerization domain containing signaling pathway |
| 76 | blueviolet | 29 | 1.3e-03 | 1.000 | 3 | GO:0016571 | BP | histone methylation |
| 77 | blueviolet | 29 | 1.3e-03 | 1.000 | 2 | GO:0048333 | BP | mesodermal cell differentiation |
| 78 | blueviolet | 29 | 1.9e-03 | 1.000 | 1 | GO:1903755 | BP | positive regulation of SUMO transferase activity |
| 79 | blueviolet | 29 | 1.9e-03 | 1.000 | 1 | GO:0034667 | CC | integrin alpha3-beta1 complex |
| 80 | blueviolet | 29 | 1.9e-03 | 1.000 | 1 | GO:0045282 | CC | plasma membrane succinate dehydrogenase complex |
| 81 | brown | 894 | 7.8e-04 | 1.000 | 3 | GO:0045541 | BP | negative regulation of cholesterol biosynthetic process |
| 82 | brown | 894 | 1.2e-03 | 1.000 | 4 | GO:0001016 | MF | RNA polymerase III regulatory region DNA binding |
| 83 | brown | 894 | 1.9e-03 | 1.000 | 3 | GO:0045875 | BP | negative regulation of sister chromatid cohesion |
| 84 | brown | 894 | 1.9e-03 | 1.000 | 3 | GO:0001032 | MF | RNA polymerase III type 3 promoter DNA binding |
| 85 | brown | 894 | 2.8e-03 | 1.000 | 6 | GO:0007143 | BP | female meiotic nuclear division |
| 86 | brown | 894 | 3.4e-03 | 1.000 | 6 | GO:1903523 | BP | negative regulation of blood circulation |
| 87 | brown | 894 | 3.5e-03 | 1.000 | 2 | GO:0007147 | BP | female meiosis II |
| 88 | brown | 894 | 3.5e-03 | 1.000 | 2 | GO:0010705 | BP | meiotic DNA double-strand break processing involved in reciprocal meiotic recombination |
| 89 | brown | 894 | 3.5e-03 | 1.000 | 2 | GO:0010710 | BP | regulation of collagen catabolic process |
| 90 | brown | 894 | 3.5e-03 | 1.000 | 2 | GO:0046356 | BP | acetyl-CoA catabolic process |
| 91 | brown2 | 60 | 4.2e-04 | 1.000 | 2 | GO:0070383 | BP | DNA cytosine deamination |
| 92 | brown2 | 60 | 6.5e-04 | 1.000 | 3 | GO:0034656 | BP | nucleobase-containing small molecule catabolic process |
| 93 | brown2 | 60 | 8.3e-04 | 1.000 | 2 | GO:0009972 | BP | cytidine deamination |
| 94 | brown2 | 60 | 8.3e-04 | 1.000 | 2 | GO:0016554 | BP | cytidine to uridine editing |
| 95 | brown2 | 60 | 8.3e-04 | 1.000 | 2 | GO:0034975 | BP | protein folding in endoplasmic reticulum |
| 96 | brown2 | 60 | 8.3e-04 | 1.000 | 2 | GO:0045006 | BP | DNA deamination |
| 97 | brown2 | 60 | 8.3e-04 | 1.000 | 2 | GO:0045869 | BP | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| 98 | brown2 | 60 | 8.3e-04 | 1.000 | 2 | GO:0004126 | MF | cytidine deaminase activity |
| 99 | brown2 | 60 | 1.4e-03 | 1.000 | 2 | GO:0045091 | BP | regulation of single stranded viral RNA replication via double stranded DNA intermediate |
| 100 | brown2 | 60 | 1.6e-03 | 1.000 | 2 | GO:0039692 | BP | single stranded viral RNA replication via double stranded DNA intermediate |
| 101 | brown4 | 86 | 9.1e-05 | 1.000 | 2 | GO:0072218 | BP | metanephric ascending thin limb development |
| 102 | brown4 | 86 | 9.1e-05 | 1.000 | 2 | GO:0072236 | BP | metanephric loop of Henle development |
| 103 | brown4 | 86 | 3.0e-04 | 1.000 | 2 | GO:0042262 | BP | DNA protection |
| 104 | brown4 | 86 | 3.0e-04 | 1.000 | 2 | GO:0036396 | CC | RNA N6-methyladenosine methyltransferase complex |
| 105 | brown4 | 86 | 4.5e-04 | 1.000 | 2 | GO:0072235 | BP | metanephric distal tubule development |
| 106 | brown4 | 86 | 4.9e-04 | 1.000 | 4 | GO:0001510 | BP | RNA methylation |
| 107 | brown4 | 86 | 6.1e-04 | 1.000 | 4 | GO:0060170 | CC | ciliary membrane |
| 108 | brown4 | 86 | 8.3e-04 | 1.000 | 2 | GO:0009204 | BP | deoxyribonucleoside triphosphate catabolic process |
| 109 | brown4 | 86 | 1.1e-03 | 1.000 | 2 | GO:0018298 | BP | protein-chromophore linkage |
| 110 | brown4 | 86 | 1.1e-03 | 1.000 | 2 | GO:0072070 | BP | loop of Henle development |
| 111 | coral | 44 | 7.7e-04 | 1.000 | 2 | GO:0005662 | CC | DNA replication factor A complex |
| 112 | coral | 44 | 2.5e-03 | 1.000 | 2 | GO:0030894 | CC | replisome |
| 113 | coral | 44 | 3.0e-03 | 1.000 | 1 | GO:0000435 | BP | positive regulation of transcription from RNA polymerase II promoter by galactose |
| 114 | coral | 44 | 3.0e-03 | 1.000 | 1 | GO:0006435 | BP | threonyl-tRNA aminoacylation |
| 115 | coral | 44 | 3.0e-03 | 1.000 | 1 | GO:0010902 | BP | positive regulation of very-low-density lipoprotein particle remodeling |
| 116 | coral | 44 | 3.0e-03 | 1.000 | 1 | GO:0070159 | BP | mitochondrial threonyl-tRNA aminoacylation |
| 117 | coral | 44 | 3.0e-03 | 1.000 | 1 | GO:0071348 | BP | cellular response to interleukin-11 |
| 118 | coral | 44 | 3.0e-03 | 1.000 | 1 | GO:0071584 | BP | negative regulation of zinc ion transmembrane import |
| 119 | coral | 44 | 3.0e-03 | 1.000 | 1 | GO:0071585 | BP | detoxification of cadmium ion |
| 120 | coral | 44 | 3.0e-03 | 1.000 | 1 | GO:1902684 | BP | negative regulation of receptor localization to synapse |
| 121 | coral1 | 58 | 8.0e-04 | 1.000 | 2 | GO:1901077 | BP | regulation of relaxation of muscle |
| 122 | coral1 | 58 | 2.7e-03 | 1.000 | 9 | GO:0006396 | BP | RNA processing |
| 123 | coral1 | 58 | 3.0e-03 | 1.000 | 3 | GO:0007589 | BP | body fluid secretion |
| 124 | coral1 | 58 | 3.9e-03 | 1.000 | 1 | GO:2000570 | BP | positive regulation of T-helper 2 cell activation |
| 125 | coral1 | 58 | 3.9e-03 | 1.000 | 1 | GO:2001213 | BP | negative regulation of vasculogenesis |
| 126 | coral1 | 58 | 3.9e-03 | 1.000 | 1 | GO:0004855 | MF | xanthine oxidase activity |
| 127 | coral1 | 58 | 4.2e-03 | 1.000 | 2 | GO:0090075 | BP | relaxation of muscle |
| 128 | coral1 | 58 | 4.2e-03 | 1.000 | 2 | GO:0031624 | MF | ubiquitin conjugating enzyme binding |
| 129 | coral1 | 58 | 4.3e-03 | 1.000 | 8 | GO:1990904 | CC | ribonucleoprotein complex |
| 130 | coral1 | 58 | 5.3e-03 | 1.000 | 2 | GO:0008266 | MF | poly(U) RNA binding |
| 131 | coral2 | 66 | 1.6e-04 | 1.000 | 3 | GO:0048019 | MF | receptor antagonist activity |
| 132 | coral2 | 66 | 3.4e-04 | 1.000 | 3 | GO:0030547 | MF | receptor inhibitor activity |
| 133 | coral2 | 66 | 3.8e-04 | 1.000 | 2 | GO:1904491 | BP | protein localization to ciliary transition zone |
| 134 | coral2 | 66 | 4.1e-04 | 1.000 | 20 | GO:0071310 | BP | cellular response to organic substance |
| 135 | coral2 | 66 | 5.0e-04 | 1.000 | 2 | GO:0045759 | BP | negative regulation of action potential |
| 136 | coral2 | 66 | 6.0e-04 | 1.000 | 12 | GO:0034097 | BP | response to cytokine |
| 137 | coral2 | 66 | 8.0e-04 | 1.000 | 2 | GO:0001967 | BP | suckling behavior |
| 138 | coral2 | 66 | 8.0e-04 | 1.000 | 2 | GO:0039706 | MF | co-receptor binding |
| 139 | coral2 | 66 | 9.5e-04 | 1.000 | 3 | GO:0021545 | BP | cranial nerve development |
| 140 | coral2 | 66 | 9.5e-04 | 1.000 | 3 | GO:2000272 | BP | negative regulation of signaling receptor activity |
| 141 | coral3 | 41 | 2.0e-04 | 1.000 | 8 | GO:0030162 | BP | regulation of proteolysis |
| 142 | coral3 | 41 | 9.4e-04 | 1.000 | 5 | GO:0045861 | BP | negative regulation of proteolysis |
| 143 | coral3 | 41 | 1.4e-03 | 1.000 | 4 | GO:0043281 | BP | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| 144 | coral3 | 41 | 1.5e-03 | 1.000 | 11 | GO:0006508 | BP | proteolysis |
| 145 | coral3 | 41 | 1.6e-03 | 1.000 | 3 | GO:1904949 | CC | ATPase complex |
| 146 | coral3 | 41 | 2.1e-03 | 1.000 | 5 | GO:0052548 | BP | regulation of endopeptidase activity |
| 147 | coral3 | 41 | 2.1e-03 | 1.000 | 4 | GO:2000116 | BP | regulation of cysteine-type endopeptidase activity |
| 148 | coral3 | 41 | 2.3e-03 | 1.000 | 2 | GO:0006929 | BP | substrate-dependent cell migration |
| 149 | coral3 | 41 | 2.5e-03 | 1.000 | 2 | GO:0030511 | BP | positive regulation of transforming growth factor beta receptor signaling pathway |
| 150 | coral3 | 41 | 2.7e-03 | 1.000 | 5 | GO:0052547 | BP | regulation of peptidase activity |
| 151 | cyan | 235 | 6.8e-06 | 0.120 | 4 | GO:0050862 | BP | positive regulation of T cell receptor signaling pathway |
| 152 | cyan | 235 | 9.1e-05 | 1.000 | 4 | GO:0050857 | BP | positive regulation of antigen receptor-mediated signaling pathway |
| 153 | cyan | 235 | 2.0e-04 | 1.000 | 3 | GO:0019532 | BP | oxalate transport |
| 154 | cyan | 235 | 2.0e-04 | 1.000 | 3 | GO:0008061 | MF | chitin binding |
| 155 | cyan | 235 | 2.0e-04 | 1.000 | 3 | GO:0019531 | MF | oxalate transmembrane transporter activity |
| 156 | cyan | 235 | 4.1e-04 | 1.000 | 4 | GO:0071480 | BP | cellular response to gamma radiation |
| 157 | cyan | 235 | 4.2e-04 | 1.000 | 3 | GO:0008271 | MF | secondary active sulfate transmembrane transporter activity |
| 158 | cyan | 235 | 4.8e-04 | 1.000 | 4 | GO:0015301 | MF | anion:anion antiporter activity |
| 159 | cyan | 235 | 8.0e-04 | 1.000 | 5 | GO:0031526 | CC | brush border membrane |
| 160 | cyan | 235 | 9.6e-04 | 1.000 | 3 | GO:0090343 | BP | positive regulation of cell aging |
| 161 | darkgreen | 136 | 2.3e-04 | 1.000 | 2 | GO:0016933 | MF | extracellularly glycine-gated ion channel activity |
| 162 | darkgreen | 136 | 2.3e-04 | 1.000 | 2 | GO:0016934 | MF | extracellularly glycine-gated chloride channel activity |
| 163 | darkgreen | 136 | 4.6e-04 | 1.000 | 2 | GO:0098690 | CC | glycinergic synapse |
| 164 | darkgreen | 136 | 7.7e-04 | 1.000 | 2 | GO:0060012 | BP | synaptic transmission, glycinergic |
| 165 | darkgreen | 136 | 1.7e-03 | 1.000 | 3 | GO:0010762 | BP | regulation of fibroblast migration |
| 166 | darkgreen | 136 | 2.0e-03 | 1.000 | 5 | GO:0002020 | MF | protease binding |
| 167 | darkgreen | 136 | 3.1e-03 | 1.000 | 3 | GO:0010761 | BP | fibroblast migration |
| 168 | darkgreen | 136 | 3.4e-03 | 1.000 | 2 | GO:0005237 | MF | inhibitory extracellular ligand-gated ion channel activity |
| 169 | darkgreen | 136 | 4.1e-03 | 1.000 | 2 | GO:0009437 | BP | carnitine metabolic process |
| 170 | darkgreen | 136 | 5.3e-03 | 1.000 | 3 | GO:0002711 | BP | positive regulation of T cell mediated immunity |
| 171 | darkgrey | 121 | 1.0e-04 | 1.000 | 8 | GO:0007266 | BP | Rho protein signal transduction |
| 172 | darkgrey | 121 | 2.1e-04 | 1.000 | 10 | GO:0032970 | BP | regulation of actin filament-based process |
| 173 | darkgrey | 121 | 3.6e-04 | 1.000 | 9 | GO:0051480 | BP | regulation of cytosolic calcium ion concentration |
| 174 | darkgrey | 121 | 3.8e-04 | 1.000 | 9 | GO:0032956 | BP | regulation of actin cytoskeleton organization |
| 175 | darkgrey | 121 | 3.9e-04 | 1.000 | 2 | GO:0060620 | BP | regulation of cholesterol import |
| 176 | darkgrey | 121 | 4.3e-04 | 1.000 | 10 | GO:0019216 | BP | regulation of lipid metabolic process |
| 177 | darkgrey | 121 | 4.6e-04 | 1.000 | 3 | GO:0002407 | BP | dendritic cell chemotaxis |
| 178 | darkgrey | 121 | 7.2e-04 | 1.000 | 3 | GO:0036336 | BP | dendritic cell migration |
| 179 | darkgrey | 121 | 7.5e-04 | 1.000 | 6 | GO:0051017 | BP | actin filament bundle assembly |
| 180 | darkgrey | 121 | 7.8e-04 | 1.000 | 6 | GO:0061572 | BP | actin filament bundle organization |
| 181 | darkmagenta | 99 | 5.1e-05 | 0.920 | 4 | GO:0014047 | BP | glutamate secretion |
| 182 | darkmagenta | 99 | 1.3e-04 | 1.000 | 7 | GO:0099003 | BP | vesicle-mediated transport in synapse |
| 183 | darkmagenta | 99 | 3.9e-04 | 1.000 | 5 | GO:0098693 | BP | regulation of synaptic vesicle cycle |
| 184 | darkmagenta | 99 | 4.5e-04 | 1.000 | 4 | GO:0048786 | CC | presynaptic active zone |
| 185 | darkmagenta | 99 | 4.7e-04 | 1.000 | 5 | GO:0060968 | BP | regulation of gene silencing |
| 186 | darkmagenta | 99 | 5.9e-04 | 1.000 | 3 | GO:0022616 | BP | DNA strand elongation |
| 187 | darkmagenta | 99 | 6.1e-04 | 1.000 | 6 | GO:0099504 | BP | synaptic vesicle cycle |
| 188 | darkmagenta | 99 | 6.5e-04 | 1.000 | 2 | GO:0030174 | BP | regulation of DNA-dependent DNA replication initiation |
| 189 | darkmagenta | 99 | 8.1e-04 | 1.000 | 4 | GO:0005657 | CC | replication fork |
| 190 | darkmagenta | 99 | 8.4e-04 | 1.000 | 9 | GO:0098793 | CC | presynapse |
| 191 | darkolivegreen | 88 | 7.1e-04 | 1.000 | 2 | GO:0035881 | BP | amacrine cell differentiation |
| 192 | darkolivegreen | 88 | 8.0e-04 | 1.000 | 6 | GO:0005085 | MF | guanyl-nucleotide exchange factor activity |
| 193 | darkolivegreen | 88 | 2.4e-03 | 1.000 | 34 | GO:0016070 | BP | RNA metabolic process |
| 194 | darkolivegreen | 88 | 3.0e-03 | 1.000 | 2 | GO:0042834 | MF | peptidoglycan binding |
| 195 | darkolivegreen | 88 | 4.9e-03 | 1.000 | 4 | GO:0043484 | BP | regulation of RNA splicing |
| 196 | darkolivegreen | 88 | 5.5e-03 | 1.000 | 2 | GO:0070530 | MF | K63-linked polyubiquitin modification-dependent protein binding |
| 197 | darkolivegreen | 88 | 5.9e-03 | 1.000 | 1 | GO:0001193 | BP | maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter |
| 198 | darkolivegreen | 88 | 5.9e-03 | 1.000 | 1 | GO:0001680 | BP | tRNA 3’-terminal CCA addition |
| 199 | darkolivegreen | 88 | 5.9e-03 | 1.000 | 1 | GO:0003350 | BP | pulmonary myocardium development |
| 200 | darkolivegreen | 88 | 5.9e-03 | 1.000 | 1 | GO:0008617 | BP | guanosine metabolic process |
| 201 | darkolivegreen2 | 31 | 1.6e-04 | 1.000 | 2 | GO:0014894 | BP | response to denervation involved in regulation of muscle adaptation |
| 202 | darkolivegreen2 | 31 | 1.9e-04 | 1.000 | 3 | GO:0006513 | BP | protein monoubiquitination |
| 203 | darkolivegreen2 | 31 | 2.0e-04 | 1.000 | 2 | GO:0014870 | BP | response to muscle inactivity |
| 204 | darkolivegreen2 | 31 | 2.9e-04 | 1.000 | 2 | GO:0014854 | BP | response to inactivity |
| 205 | darkolivegreen2 | 31 | 2.9e-04 | 1.000 | 2 | GO:0045820 | BP | negative regulation of glycolytic process |
| 206 | darkolivegreen2 | 31 | 4.3e-04 | 1.000 | 4 | GO:0019722 | BP | calcium-mediated signaling |
| 207 | darkolivegreen2 | 31 | 4.6e-04 | 1.000 | 2 | GO:2001170 | BP | negative regulation of ATP biosynthetic process |
| 208 | darkolivegreen2 | 31 | 1.2e-03 | 1.000 | 2 | GO:1903579 | BP | negative regulation of ATP metabolic process |
| 209 | darkolivegreen2 | 31 | 1.4e-03 | 1.000 | 2 | GO:0045980 | BP | negative regulation of nucleotide metabolic process |
| 210 | darkolivegreen2 | 31 | 2.2e-03 | 1.000 | 1 | GO:0046338 | BP | phosphatidylethanolamine catabolic process |
| 211 | darkolivegreen4 | 56 | 3.1e-06 | 0.057 | 4 | GO:0033363 | BP | secretory granule organization |
| 212 | darkolivegreen4 | 56 | 6.3e-04 | 1.000 | 2 | GO:0008525 | MF | phosphatidylcholine transporter activity |
| 213 | darkolivegreen4 | 56 | 9.2e-04 | 1.000 | 2 | GO:0001675 | BP | acrosome assembly |
| 214 | darkolivegreen4 | 56 | 2.1e-03 | 1.000 | 2 | GO:0000146 | MF | microfilament motor activity |
| 215 | darkolivegreen4 | 56 | 2.6e-03 | 1.000 | 2 | GO:0022627 | CC | cytosolic small ribosomal subunit |
| 216 | darkolivegreen4 | 56 | 3.1e-03 | 1.000 | 3 | GO:0006497 | BP | protein lipidation |
| 217 | darkolivegreen4 | 56 | 3.1e-03 | 1.000 | 3 | GO:0051651 | BP | maintenance of location in cell |
| 218 | darkolivegreen4 | 56 | 3.6e-03 | 1.000 | 3 | GO:0042158 | BP | lipoprotein biosynthetic process |
| 219 | darkolivegreen4 | 56 | 3.7e-03 | 1.000 | 2 | GO:0051125 | BP | regulation of actin nucleation |
| 220 | darkolivegreen4 | 56 | 3.8e-03 | 1.000 | 1 | GO:0018191 | BP | peptidyl-serine octanoylation |
| 221 | darkorange | 118 | 4.8e-04 | 1.000 | 4 | GO:0075733 | BP | intracellular transport of virus |
| 222 | darkorange | 118 | 1.2e-03 | 1.000 | 4 | GO:0043657 | CC | host cell |
| 223 | darkorange | 118 | 1.2e-03 | 1.000 | 2 | GO:0086016 | BP | AV node cell action potential |
| 224 | darkorange | 118 | 1.2e-03 | 1.000 | 2 | GO:0086027 | BP | AV node cell to bundle of His cell signaling |
| 225 | darkorange | 118 | 1.2e-03 | 1.000 | 2 | GO:0086067 | BP | AV node cell to bundle of His cell communication |
| 226 | darkorange | 118 | 1.4e-03 | 1.000 | 3 | GO:0005484 | MF | SNAP receptor activity |
| 227 | darkorange | 118 | 1.5e-03 | 1.000 | 4 | GO:0044216 | CC | other organism cell |
| 228 | darkorange | 118 | 1.6e-03 | 1.000 | 2 | GO:0045254 | CC | pyruvate dehydrogenase complex |
| 229 | darkorange | 118 | 3.9e-03 | 1.000 | 3 | GO:0003823 | MF | antigen binding |
| 230 | darkorange | 118 | 4.5e-03 | 1.000 | 3 | GO:0031201 | CC | SNARE complex |
| 231 | darkorange2 | 86 | 1.2e-03 | 1.000 | 3 | GO:0043209 | CC | myelin sheath |
| 232 | darkorange2 | 86 | 1.7e-03 | 1.000 | 3 | GO:0042220 | BP | response to cocaine |
| 233 | darkorange2 | 86 | 1.9e-03 | 1.000 | 8 | GO:0010008 | CC | endosome membrane |
| 234 | darkorange2 | 86 | 2.4e-03 | 1.000 | 2 | GO:0005248 | MF | voltage-gated sodium channel activity |
| 235 | darkorange2 | 86 | 2.5e-03 | 1.000 | 6 | GO:0005261 | MF | cation channel activity |
| 236 | darkorange2 | 86 | 2.8e-03 | 1.000 | 2 | GO:0048148 | BP | behavioral response to cocaine |
| 237 | darkorange2 | 86 | 3.6e-03 | 1.000 | 2 | GO:0060008 | BP | Sertoli cell differentiation |
| 238 | darkorange2 | 86 | 3.8e-03 | 1.000 | 4 | GO:0032680 | BP | regulation of tumor necrosis factor production |
| 239 | darkorange2 | 86 | 4.2e-03 | 1.000 | 4 | GO:0032640 | BP | tumor necrosis factor production |
| 240 | darkorange2 | 86 | 4.7e-03 | 1.000 | 4 | GO:0031901 | CC | early endosome membrane |
| 241 | darkred | 157 | 3.5e-05 | 0.640 | 3 | GO:0046877 | BP | regulation of saliva secretion |
| 242 | darkred | 157 | 1.0e-04 | 1.000 | 2 | GO:0035545 | BP | determination of left/right asymmetry in nervous system |
| 243 | darkred | 157 | 1.6e-04 | 1.000 | 3 | GO:0046541 | BP | saliva secretion |
| 244 | darkred | 157 | 3.1e-04 | 1.000 | 2 | GO:0071626 | BP | mastication |
| 245 | darkred | 157 | 3.1e-04 | 1.000 | 2 | GO:0090234 | BP | regulation of kinetochore assembly |
| 246 | darkred | 157 | 3.1e-04 | 1.000 | 2 | GO:0098583 | BP | learned vocalization behavior |
| 247 | darkred | 157 | 3.1e-04 | 1.000 | 2 | GO:1905747 | BP | negative regulation of saliva secretion |
| 248 | darkred | 157 | 3.1e-04 | 1.000 | 2 | GO:1905748 | BP | hard palate morphogenesis |
| 249 | darkred | 157 | 6.1e-04 | 1.000 | 2 | GO:0090230 | BP | regulation of centromere complex assembly |
| 250 | darkred | 157 | 6.1e-04 | 1.000 | 2 | GO:0090521 | BP | glomerular visceral epithelial cell migration |
| 251 | darkseagreen3 | 45 | 9.4e-04 | 1.000 | 3 | GO:0016925 | BP | protein sumoylation |
| 252 | darkseagreen3 | 45 | 1.0e-03 | 1.000 | 2 | GO:0005849 | CC | mRNA cleavage factor complex |
| 253 | darkseagreen3 | 45 | 1.3e-03 | 1.000 | 6 | GO:0005813 | CC | centrosome |
| 254 | darkseagreen3 | 45 | 1.5e-03 | 1.000 | 2 | GO:0006379 | BP | mRNA cleavage |
| 255 | darkseagreen3 | 45 | 1.6e-03 | 1.000 | 9 | GO:0015630 | CC | microtubule cytoskeleton |
| 256 | darkseagreen3 | 45 | 2.8e-03 | 1.000 | 1 | GO:0036372 | BP | opsin transport |
| 257 | darkseagreen3 | 45 | 2.8e-03 | 1.000 | 1 | GO:1905454 | BP | negative regulation of myeloid progenitor cell differentiation |
| 258 | darkseagreen3 | 45 | 2.8e-03 | 1.000 | 1 | GO:0005898 | CC | interleukin-13 receptor complex |
| 259 | darkseagreen3 | 45 | 2.8e-03 | 1.000 | 1 | GO:0016028 | CC | rhabdomere |
| 260 | darkseagreen3 | 45 | 2.8e-03 | 1.000 | 1 | GO:0004031 | MF | aldehyde oxidase activity |
| 261 | darkseagreen4 | 61 | 1.0e-03 | 1.000 | 2 | GO:0055106 | MF | ubiquitin-protein transferase regulator activity |
| 262 | darkseagreen4 | 61 | 1.2e-03 | 1.000 | 4 | GO:0070851 | MF | growth factor receptor binding |
| 263 | darkseagreen4 | 61 | 2.1e-03 | 1.000 | 3 | GO:0030193 | BP | regulation of blood coagulation |
| 264 | darkseagreen4 | 61 | 2.3e-03 | 1.000 | 6 | GO:0046982 | MF | protein heterodimerization activity |
| 265 | darkseagreen4 | 61 | 2.6e-03 | 1.000 | 2 | GO:0035902 | BP | response to immobilization stress |
| 266 | darkseagreen4 | 61 | 2.8e-03 | 1.000 | 8 | GO:0019221 | BP | cytokine-mediated signaling pathway |
| 267 | darkseagreen4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0007014 | BP | actin ubiquitination |
| 268 | darkseagreen4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0036371 | BP | protein localization to T-tubule |
| 269 | darkseagreen4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0072254 | BP | metanephric glomerular mesangial cell differentiation |
| 270 | darkseagreen4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0072255 | BP | metanephric glomerular mesangial cell development |
| 271 | darkslateblue | 80 | 1.7e-04 | 1.000 | 2 | GO:2001199 | BP | negative regulation of dendritic cell differentiation |
| 272 | darkslateblue | 80 | 1.7e-04 | 1.000 | 2 | GO:0097512 | CC | cardiac myofibril |
| 273 | darkslateblue | 80 | 5.8e-04 | 1.000 | 2 | GO:1904153 | BP | negative regulation of retrograde protein transport, ER to cytosol |
| 274 | darkslateblue | 80 | 7.7e-04 | 1.000 | 2 | GO:0010501 | BP | RNA secondary structure unwinding |
| 275 | darkslateblue | 80 | 7.7e-04 | 1.000 | 2 | GO:0070862 | BP | negative regulation of protein exit from endoplasmic reticulum |
| 276 | darkslateblue | 80 | 9.9e-04 | 1.000 | 2 | GO:0070922 | BP | small RNA loading onto RISC |
| 277 | darkslateblue | 80 | 9.9e-04 | 1.000 | 2 | GO:2001198 | BP | regulation of dendritic cell differentiation |
| 278 | darkslateblue | 80 | 1.2e-03 | 1.000 | 2 | GO:0046929 | BP | negative regulation of neurotransmitter secretion |
| 279 | darkslateblue | 80 | 1.2e-03 | 1.000 | 2 | GO:1904152 | BP | regulation of retrograde protein transport, ER to cytosol |
| 280 | darkslateblue | 80 | 1.2e-03 | 1.000 | 2 | GO:1904293 | BP | negative regulation of ERAD pathway |
| 281 | darkturquoise | 116 | 3.2e-03 | 1.000 | 2 | GO:0033033 | BP | negative regulation of myeloid cell apoptotic process |
| 282 | darkturquoise | 116 | 4.6e-03 | 1.000 | 3 | GO:0018149 | BP | peptide cross-linking |
| 283 | darkturquoise | 116 | 4.8e-03 | 1.000 | 7 | GO:0031012 | CC | extracellular matrix |
| 284 | darkturquoise | 116 | 5.6e-03 | 1.000 | 3 | GO:0001533 | CC | cornified envelope |
| 285 | darkturquoise | 116 | 6.0e-03 | 1.000 | 2 | GO:0001964 | BP | startle response |
| 286 | darkturquoise | 116 | 6.8e-03 | 1.000 | 2 | GO:0007096 | BP | regulation of exit from mitosis |
| 287 | darkturquoise | 116 | 7.8e-03 | 1.000 | 1 | GO:0010780 | BP | meiotic DNA double-strand break formation involved in reciprocal meiotic recombination |
| 288 | darkturquoise | 116 | 7.8e-03 | 1.000 | 1 | GO:0052314 | BP | phytoalexin metabolic process |
| 289 | darkturquoise | 116 | 7.8e-03 | 1.000 | 1 | GO:0060007 | BP | linear vestibuloocular reflex |
| 290 | darkturquoise | 116 | 7.8e-03 | 1.000 | 1 | GO:0060820 | BP | inactivation of X chromosome by heterochromatin assembly |
| 291 | darkviolet | 58 | 2.4e-04 | 1.000 | 2 | GO:0015129 | MF | lactate transmembrane transporter activity |
| 292 | darkviolet | 58 | 3.3e-04 | 1.000 | 2 | GO:0015727 | BP | lactate transport |
| 293 | darkviolet | 58 | 3.3e-04 | 1.000 | 2 | GO:0035873 | BP | lactate transmembrane transport |
| 294 | darkviolet | 58 | 2.9e-03 | 1.000 | 2 | GO:0060972 | BP | left/right pattern formation |
| 295 | darkviolet | 58 | 4.0e-03 | 1.000 | 1 | GO:0000494 | BP | box C/D snoRNA 3’-end processing |
| 296 | darkviolet | 58 | 4.0e-03 | 1.000 | 1 | GO:0035780 | BP | CD80 biosynthetic process |
| 297 | darkviolet | 58 | 4.0e-03 | 1.000 | 1 | GO:0035781 | BP | CD86 biosynthetic process |
| 298 | darkviolet | 58 | 4.0e-03 | 1.000 | 1 | GO:0046588 | BP | negative regulation of calcium-dependent cell-cell adhesion |
| 299 | darkviolet | 58 | 4.0e-03 | 1.000 | 1 | GO:1905580 | BP | positive regulation of ERBB3 signaling pathway |
| 300 | darkviolet | 58 | 4.0e-03 | 1.000 | 1 | GO:1905590 | BP | fibronectin fibril organization |
| 301 | deeppink | 29 | 7.0e-04 | 1.000 | 3 | GO:0006493 | BP | protein O-linked glycosylation |
| 302 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0016269 | BP | O-glycan processing, core 3 |
| 303 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0045556 | BP | positive regulation of TRAIL biosynthetic process |
| 304 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0062026 | BP | negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process |
| 305 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:1900095 | BP | regulation of dosage compensation by inactivation of X chromosome |
| 306 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:1904947 | BP | folate import into mitochondrion |
| 307 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:2000612 | BP | regulation of thyroid-stimulating hormone secretion |
| 308 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0005586 | CC | collagen type III trimer |
| 309 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0047224 | MF | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity |
| 310 | deeppink | 29 | 1.9e-03 | 1.000 | 1 | GO:0070611 | MF | histone methyltransferase activity (H3-R2 specific) |
| 311 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:0002878 | BP | negative regulation of acute inflammatory response to non-antigenic stimulus |
| 312 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:0045813 | BP | positive regulation of Wnt signaling pathway, calcium modulating pathway |
| 313 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:1901296 | BP | negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment |
| 314 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:1904723 | BP | negative regulation of Wnt-Frizzled-LRP5/6 complex assembly |
| 315 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:1905607 | BP | negative regulation of presynapse assembly |
| 316 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:0000334 | MF | 3-hydroxyanthranilate 3,4-dioxygenase activity |
| 317 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:0015292 | MF | uniporter activity |
| 318 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:0015633 | MF | zinc-transporting ATPase activity |
| 319 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:0016521 | MF | pituitary adenylate cyclase activating polypeptide activity |
| 320 | firebrick3 | 35 | 2.2e-03 | 1.000 | 1 | GO:0019978 | MF | interleukin-3 binding |
| 321 | firebrick4 | 61 | 8.5e-04 | 1.000 | 2 | GO:0007158 | BP | neuron cell-cell adhesion |
| 322 | firebrick4 | 61 | 2.3e-03 | 1.000 | 2 | GO:0009220 | BP | pyrimidine ribonucleotide biosynthetic process |
| 323 | firebrick4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0006147 | BP | guanine catabolic process |
| 324 | firebrick4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0006173 | BP | dADP biosynthetic process |
| 325 | firebrick4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0006427 | BP | histidyl-tRNA aminoacylation |
| 326 | firebrick4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0007387 | BP | anterior compartment pattern formation |
| 327 | firebrick4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0007388 | BP | posterior compartment specification |
| 328 | firebrick4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0035351 | BP | heme transmembrane transport |
| 329 | firebrick4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0043438 | BP | acetoacetic acid metabolic process |
| 330 | firebrick4 | 61 | 4.0e-03 | 1.000 | 1 | GO:0004503 | MF | monophenol monooxygenase activity |
| 331 | floralwhite | 85 | 1.4e-03 | 1.000 | 2 | GO:0044615 | CC | nuclear pore nuclear basket |
| 332 | floralwhite | 85 | 1.4e-03 | 1.000 | 6 | GO:0000082 | BP | G1/S transition of mitotic cell cycle |
| 333 | floralwhite | 85 | 1.7e-03 | 1.000 | 6 | GO:0044843 | BP | cell cycle G1/S phase transition |
| 334 | floralwhite | 85 | 1.9e-03 | 1.000 | 4 | GO:2000134 | BP | negative regulation of G1/S transition of mitotic cell cycle |
| 335 | floralwhite | 85 | 2.2e-03 | 1.000 | 4 | GO:1902807 | BP | negative regulation of cell cycle G1/S phase transition |
| 336 | floralwhite | 85 | 2.7e-03 | 1.000 | 2 | GO:0008278 | CC | cohesin complex |
| 337 | floralwhite | 85 | 3.1e-03 | 1.000 | 4 | GO:0005319 | MF | lipid transporter activity |
| 338 | floralwhite | 85 | 3.2e-03 | 1.000 | 5 | GO:0007584 | BP | response to nutrient |
| 339 | floralwhite | 85 | 5.1e-03 | 1.000 | 4 | GO:0042129 | BP | regulation of T cell proliferation |
| 340 | floralwhite | 85 | 5.1e-03 | 1.000 | 8 | GO:0044772 | BP | mitotic cell cycle phase transition |
| 341 | green | 676 | 3.7e-05 | 0.660 | 35 | GO:0051606 | BP | detection of stimulus |
| 342 | green | 676 | 6.0e-05 | 1.000 | 26 | GO:0007606 | BP | sensory perception of chemical stimulus |
| 343 | green | 676 | 6.8e-05 | 1.000 | 26 | GO:0050906 | BP | detection of stimulus involved in sensory perception |
| 344 | green | 676 | 7.3e-05 | 1.000 | 22 | GO:0007608 | BP | sensory perception of smell |
| 345 | green | 676 | 1.2e-04 | 1.000 | 4 | GO:0030210 | BP | heparin biosynthetic process |
| 346 | green | 676 | 1.5e-04 | 1.000 | 20 | GO:0050911 | BP | detection of chemical stimulus involved in sensory perception of smell |
| 347 | green | 676 | 1.5e-04 | 1.000 | 20 | GO:0004984 | MF | olfactory receptor activity |
| 348 | green | 676 | 2.2e-04 | 1.000 | 24 | GO:0009593 | BP | detection of chemical stimulus |
| 349 | green | 676 | 2.2e-04 | 1.000 | 7 | GO:0021955 | BP | central nervous system neuron axonogenesis |
| 350 | green | 676 | 2.4e-04 | 1.000 | 22 | GO:0050907 | BP | detection of chemical stimulus involved in sensory perception |
| 351 | greenyellow | 260 | 2.7e-04 | 1.000 | 4 | GO:0046930 | CC | pore complex |
| 352 | greenyellow | 260 | 7.0e-04 | 1.000 | 4 | GO:0071280 | BP | cellular response to copper ion |
| 353 | greenyellow | 260 | 7.6e-04 | 1.000 | 3 | GO:0045342 | BP | MHC class II biosynthetic process |
| 354 | greenyellow | 260 | 9.6e-04 | 1.000 | 18 | GO:0072657 | BP | protein localization to membrane |
| 355 | greenyellow | 260 | 1.1e-03 | 1.000 | 4 | GO:0001782 | BP | B cell homeostasis |
| 356 | greenyellow | 260 | 1.1e-03 | 1.000 | 5 | GO:0002260 | BP | lymphocyte homeostasis |
| 357 | greenyellow | 260 | 1.7e-03 | 1.000 | 2 | GO:0061055 | BP | myotome development |
| 358 | greenyellow | 260 | 1.7e-03 | 1.000 | 2 | GO:1902262 | BP | apoptotic process involved in blood vessel morphogenesis |
| 359 | greenyellow | 260 | 1.7e-03 | 1.000 | 2 | GO:0097200 | MF | cysteine-type endopeptidase activity involved in execution phase of apoptosis |
| 360 | greenyellow | 260 | 1.8e-03 | 1.000 | 10 | GO:0015291 | MF | secondary active transmembrane transporter activity |
| 361 | grey | 370 | 5.9e-04 | 1.000 | 2 | GO:0090038 | BP | negative regulation of protein kinase C signaling |
| 362 | grey | 370 | 8.2e-04 | 1.000 | 56 | GO:0042592 | BP | homeostatic process |
| 363 | grey | 370 | 1.1e-03 | 1.000 | 3 | GO:0002430 | BP | complement receptor mediated signaling pathway |
| 364 | grey | 370 | 1.6e-03 | 1.000 | 25 | GO:0030036 | BP | actin cytoskeleton organization |
| 365 | grey | 370 | 1.7e-03 | 1.000 | 2 | GO:0034635 | BP | glutathione transport |
| 366 | grey | 370 | 1.7e-03 | 1.000 | 2 | GO:1905103 | CC | integral component of lysosomal membrane |
| 367 | grey | 370 | 1.8e-03 | 1.000 | 7 | GO:0045778 | BP | positive regulation of ossification |
| 368 | grey | 370 | 2.1e-03 | 1.000 | 6 | GO:0002920 | BP | regulation of humoral immune response |
| 369 | grey | 370 | 2.1e-03 | 1.000 | 27 | GO:0030029 | BP | actin filament-based process |
| 370 | grey | 370 | 2.4e-03 | 1.000 | 32 | GO:0019725 | BP | cellular homeostasis |
| 371 | grey60 | 195 | 2.0e-04 | 1.000 | 26 | GO:0005615 | CC | extracellular space |
| 372 | grey60 | 195 | 3.2e-04 | 1.000 | 19 | GO:0009986 | CC | cell surface |
| 373 | grey60 | 195 | 4.5e-04 | 1.000 | 4 | GO:0001893 | BP | maternal placenta development |
| 374 | grey60 | 195 | 4.5e-04 | 1.000 | 4 | GO:0006958 | BP | complement activation, classical pathway |
| 375 | grey60 | 195 | 5.1e-04 | 1.000 | 4 | GO:1902042 | BP | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| 376 | grey60 | 195 | 5.8e-04 | 1.000 | 7 | GO:0006766 | BP | vitamin metabolic process |
| 377 | grey60 | 195 | 6.3e-04 | 1.000 | 23 | GO:0046914 | MF | transition metal ion binding |
| 378 | grey60 | 195 | 9.3e-04 | 1.000 | 2 | GO:0042167 | BP | heme catabolic process |
| 379 | grey60 | 195 | 9.3e-04 | 1.000 | 2 | GO:0070579 | MF | methylcytosine dioxygenase activity |
| 380 | grey60 | 195 | 9.3e-04 | 1.000 | 4 | GO:1904036 | BP | negative regulation of epithelial cell apoptotic process |
| 381 | honeydew | 44 | 8.6e-05 | 1.000 | 2 | GO:0051891 | BP | positive regulation of cardioblast differentiation |
| 382 | honeydew | 44 | 4.1e-04 | 1.000 | 3 | GO:0004869 | MF | cysteine-type endopeptidase inhibitor activity |
| 383 | honeydew | 44 | 6.5e-04 | 1.000 | 4 | GO:0004866 | MF | endopeptidase inhibitor activity |
| 384 | honeydew | 44 | 7.4e-04 | 1.000 | 4 | GO:0030414 | MF | peptidase inhibitor activity |
| 385 | honeydew | 44 | 1.0e-03 | 1.000 | 2 | GO:0010002 | BP | cardioblast differentiation |
| 386 | honeydew | 44 | 1.3e-03 | 1.000 | 2 | GO:2000738 | BP | positive regulation of stem cell differentiation |
| 387 | honeydew | 44 | 2.2e-03 | 1.000 | 4 | GO:0010951 | BP | negative regulation of endopeptidase activity |
| 388 | honeydew | 44 | 2.3e-03 | 1.000 | 2 | GO:1905209 | BP | positive regulation of cardiocyte differentiation |
| 389 | honeydew | 44 | 2.6e-03 | 1.000 | 4 | GO:0010466 | BP | negative regulation of peptidase activity |
| 390 | honeydew | 44 | 3.0e-03 | 1.000 | 1 | GO:0002276 | BP | basophil activation involved in immune response |
| 391 | honeydew1 | 71 | 2.9e-05 | 0.530 | 3 | GO:1900363 | BP | regulation of mRNA polyadenylation |
| 392 | honeydew1 | 71 | 1.3e-04 | 1.000 | 2 | GO:2001168 | BP | positive regulation of histone H2B ubiquitination |
| 393 | honeydew1 | 71 | 1.5e-04 | 1.000 | 3 | GO:0031440 | BP | regulation of mRNA 3’-end processing |
| 394 | honeydew1 | 71 | 2.2e-04 | 1.000 | 2 | GO:0033184 | BP | positive regulation of histone ubiquitination |
| 395 | honeydew1 | 71 | 4.7e-04 | 1.000 | 2 | GO:1900364 | BP | negative regulation of mRNA polyadenylation |
| 396 | honeydew1 | 71 | 5.2e-04 | 1.000 | 3 | GO:0006378 | BP | mRNA polyadenylation |
| 397 | honeydew1 | 71 | 5.2e-04 | 1.000 | 3 | GO:0043631 | BP | RNA polyadenylation |
| 398 | honeydew1 | 71 | 6.2e-04 | 1.000 | 2 | GO:0031441 | BP | negative regulation of mRNA 3’-end processing |
| 399 | honeydew1 | 71 | 6.7e-04 | 1.000 | 3 | GO:0016574 | BP | histone ubiquitination |
| 400 | honeydew1 | 71 | 8.0e-04 | 1.000 | 2 | GO:0033182 | BP | regulation of histone ubiquitination |
| 401 | indianred3 | 36 | 1.9e-04 | 1.000 | 2 | GO:0060736 | BP | prostate gland growth |
| 402 | indianred3 | 36 | 1.9e-04 | 1.000 | 3 | GO:0071300 | BP | cellular response to retinoic acid |
| 403 | indianred3 | 36 | 2.3e-04 | 1.000 | 2 | GO:0030238 | BP | male sex determination |
| 404 | indianred3 | 36 | 3.4e-04 | 1.000 | 3 | GO:0008013 | MF | beta-catenin binding |
| 405 | indianred3 | 36 | 4.9e-04 | 1.000 | 2 | GO:0007530 | BP | sex determination |
| 406 | indianred3 | 36 | 7.9e-04 | 1.000 | 6 | GO:0048729 | BP | tissue morphogenesis |
| 407 | indianred3 | 36 | 7.9e-04 | 1.000 | 3 | GO:0032526 | BP | response to retinoic acid |
| 408 | indianred3 | 36 | 1.0e-03 | 1.000 | 4 | GO:0006310 | BP | DNA recombination |
| 409 | indianred3 | 36 | 1.1e-03 | 1.000 | 2 | GO:0060571 | BP | morphogenesis of an epithelial fold |
| 410 | indianred3 | 36 | 1.2e-03 | 1.000 | 2 | GO:0060740 | BP | prostate gland epithelium morphogenesis |
| 411 | indianred4 | 58 | 1.5e-03 | 1.000 | 3 | GO:0060395 | BP | SMAD protein signal transduction |
| 412 | indianred4 | 58 | 2.5e-03 | 1.000 | 2 | GO:0060390 | BP | regulation of SMAD protein signal transduction |
| 413 | indianred4 | 58 | 3.1e-03 | 1.000 | 2 | GO:0009083 | BP | branched-chain amino acid catabolic process |
| 414 | indianred4 | 58 | 3.4e-03 | 1.000 | 2 | GO:0031430 | CC | M band |
| 415 | indianred4 | 58 | 4.0e-03 | 1.000 | 1 | GO:0006481 | BP | C-terminal protein methylation |
| 416 | indianred4 | 58 | 4.0e-03 | 1.000 | 1 | GO:0033388 | BP | putrescine biosynthetic process from arginine |
| 417 | indianred4 | 58 | 4.0e-03 | 1.000 | 1 | GO:0033389 | BP | putrescine biosynthetic process from arginine, using agmatinase |
| 418 | indianred4 | 58 | 4.0e-03 | 1.000 | 1 | GO:0051068 | BP | dihydrolipoamide metabolic process |
| 419 | indianred4 | 58 | 4.0e-03 | 1.000 | 1 | GO:0086030 | BP | adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation |
| 420 | indianred4 | 58 | 4.0e-03 | 1.000 | 1 | GO:0003880 | MF | protein C-terminal carboxyl O-methyltransferase activity |
| 421 | ivory | 92 | 6.0e-06 | 0.110 | 4 | GO:0034123 | BP | positive regulation of toll-like receptor signaling pathway |
| 422 | ivory | 92 | 7.2e-06 | 0.130 | 4 | GO:2000482 | BP | regulation of interleukin-8 secretion |
| 423 | ivory | 92 | 1.5e-05 | 0.260 | 4 | GO:0072606 | BP | interleukin-8 secretion |
| 424 | ivory | 92 | 3.4e-05 | 0.610 | 2 | GO:0042495 | BP | detection of triacyl bacterial lipopeptide |
| 425 | ivory | 92 | 3.4e-05 | 0.610 | 2 | GO:0035354 | CC | Toll-like receptor 1-Toll-like receptor 2 protein complex |
| 426 | ivory | 92 | 6.6e-05 | 1.000 | 3 | GO:0034134 | BP | toll-like receptor 2 signaling pathway |
| 427 | ivory | 92 | 8.3e-05 | 1.000 | 3 | GO:2000484 | BP | positive regulation of interleukin-8 secretion |
| 428 | ivory | 92 | 1.0e-04 | 1.000 | 2 | GO:0038123 | BP | toll-like receptor TLR1:TLR2 signaling pathway |
| 429 | ivory | 92 | 1.0e-04 | 1.000 | 2 | GO:0042494 | BP | detection of bacterial lipoprotein |
| 430 | ivory | 92 | 1.0e-04 | 1.000 | 2 | GO:0071727 | BP | cellular response to triacyl bacterial lipopeptide |
| 431 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:0045167 | BP | asymmetric protein localization involved in cell fate determination |
| 432 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:0070145 | BP | mitochondrial asparaginyl-tRNA aminoacylation |
| 433 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:0071911 | BP | synchronous neurotransmitter secretion |
| 434 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:0098746 | BP | fast, calcium ion-dependent exocytosis of neurotransmitter |
| 435 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:0120049 | BP | snRNA (adenine-N6)-methylation |
| 436 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:1903093 | BP | regulation of protein K48-linked deubiquitination |
| 437 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:1903235 | BP | positive regulation of calcium ion-dependent exocytosis of neurotransmitter |
| 438 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:1905386 | BP | positive regulation of protein localization to presynapse |
| 439 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:0004815 | MF | aspartate-tRNA ligase activity |
| 440 | lavenderblush2 | 46 | 3.1e-03 | 1.000 | 1 | GO:0019785 | MF | ISG15-specific protease activity |
| 441 | lavenderblush3 | 69 | 5.6e-05 | 1.000 | 2 | GO:0032185 | BP | septin cytoskeleton organization |
| 442 | lavenderblush3 | 69 | 3.5e-03 | 1.000 | 5 | GO:0031647 | BP | regulation of protein stability |
| 443 | lavenderblush3 | 69 | 3.7e-03 | 1.000 | 3 | GO:0030864 | CC | cortical actin cytoskeleton |
| 444 | lavenderblush3 | 69 | 4.1e-03 | 1.000 | 2 | GO:0034162 | BP | toll-like receptor 9 signaling pathway |
| 445 | lavenderblush3 | 69 | 4.1e-03 | 1.000 | 3 | GO:0005776 | CC | autophagosome |
| 446 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0006178 | BP | guanine salvage |
| 447 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0032263 | BP | GMP salvage |
| 448 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0034156 | BP | negative regulation of toll-like receptor 7 signaling pathway |
| 449 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0036153 | BP | triglyceride acyl-chain remodeling |
| 450 | lavenderblush3 | 69 | 4.4e-03 | 1.000 | 1 | GO:0046038 | BP | GMP catabolic process |
| 451 | lightblue4 | 35 | 9.3e-04 | 1.000 | 3 | GO:0051087 | MF | chaperone binding |
| 452 | lightblue4 | 35 | 1.2e-03 | 1.000 | 9 | GO:0006629 | BP | lipid metabolic process |
| 453 | lightblue4 | 35 | 2.0e-03 | 1.000 | 2 | GO:0001580 | BP | detection of chemical stimulus involved in sensory perception of bitter taste |
| 454 | lightblue4 | 35 | 2.0e-03 | 1.000 | 2 | GO:2000279 | BP | negative regulation of DNA biosynthetic process |
| 455 | lightblue4 | 35 | 2.4e-03 | 1.000 | 1 | GO:0018979 | BP | trichloroethylene metabolic process |
| 456 | lightblue4 | 35 | 2.4e-03 | 1.000 | 1 | GO:0060683 | BP | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling |
| 457 | lightblue4 | 35 | 2.4e-03 | 1.000 | 1 | GO:0061736 | BP | engulfment of target by autophagosome |
| 458 | lightblue4 | 35 | 2.4e-03 | 1.000 | 1 | GO:0061753 | BP | substrate localization to autophagosome |
| 459 | lightblue4 | 35 | 2.4e-03 | 1.000 | 1 | GO:1902161 | BP | positive regulation of cyclic nucleotide-gated ion channel activity |
| 460 | lightblue4 | 35 | 2.4e-03 | 1.000 | 1 | GO:1990401 | BP | embryonic lung development |
| 461 | lightcoral | 57 | 8.2e-05 | 1.000 | 2 | GO:0042536 | BP | negative regulation of tumor necrosis factor biosynthetic process |
| 462 | lightcoral | 57 | 1.4e-03 | 1.000 | 2 | GO:0035809 | BP | regulation of urine volume |
| 463 | lightcoral | 57 | 1.8e-03 | 1.000 | 4 | GO:0007093 | BP | mitotic cell cycle checkpoint |
| 464 | lightcoral | 57 | 1.9e-03 | 1.000 | 4 | GO:0030496 | CC | midbody |
| 465 | lightcoral | 57 | 2.3e-03 | 1.000 | 2 | GO:0042534 | BP | regulation of tumor necrosis factor biosynthetic process |
| 466 | lightcoral | 57 | 3.0e-03 | 1.000 | 2 | GO:0042573 | BP | retinoic acid metabolic process |
| 467 | lightcoral | 57 | 3.4e-03 | 1.000 | 5 | GO:0040013 | BP | negative regulation of locomotion |
| 468 | lightcoral | 57 | 3.7e-03 | 1.000 | 1 | GO:0001100 | BP | negative regulation of exit from mitosis |
| 469 | lightcoral | 57 | 3.7e-03 | 1.000 | 1 | GO:0015730 | BP | propanoate transport |
| 470 | lightcoral | 57 | 3.7e-03 | 1.000 | 1 | GO:0015913 | BP | short-chain fatty acid import |
| 471 | lightcyan | 190 | 9.8e-04 | 1.000 | 2 | GO:0015855 | BP | pyrimidine nucleobase transport |
| 472 | lightcyan | 190 | 2.2e-03 | 1.000 | 6 | GO:0052689 | MF | carboxylic ester hydrolase activity |
| 473 | lightcyan | 190 | 3.3e-03 | 1.000 | 2 | GO:0006863 | BP | purine nucleobase transport |
| 474 | lightcyan | 190 | 4.4e-03 | 1.000 | 2 | GO:0048484 | BP | enteric nervous system development |
| 475 | lightcyan | 190 | 5.6e-03 | 1.000 | 2 | GO:0015851 | BP | nucleobase transport |
| 476 | lightcyan | 190 | 5.6e-03 | 1.000 | 2 | GO:0034663 | CC | endoplasmic reticulum chaperone complex |
| 477 | lightcyan | 190 | 5.6e-03 | 1.000 | 2 | GO:0098981 | CC | cholinergic synapse |
| 478 | lightcyan | 190 | 5.6e-03 | 1.000 | 2 | GO:0072542 | MF | protein phosphatase activator activity |
| 479 | lightcyan | 190 | 5.8e-03 | 1.000 | 4 | GO:0010633 | BP | negative regulation of epithelial cell migration |
| 480 | lightcyan | 190 | 7.0e-03 | 1.000 | 2 | GO:0060394 | BP | negative regulation of pathway-restricted SMAD protein phosphorylation |
| 481 | lightcyan1 | 86 | 3.2e-05 | 0.580 | 2 | GO:0061031 | BP | endodermal digestive tract morphogenesis |
| 482 | lightcyan1 | 86 | 1.7e-04 | 1.000 | 6 | GO:0071466 | BP | cellular response to xenobiotic stimulus |
| 483 | lightcyan1 | 86 | 8.6e-04 | 1.000 | 10 | GO:0031966 | CC | mitochondrial membrane |
| 484 | lightcyan1 | 86 | 1.4e-03 | 1.000 | 10 | GO:0005740 | CC | mitochondrial envelope |
| 485 | lightcyan1 | 86 | 1.7e-03 | 1.000 | 2 | GO:0060080 | BP | inhibitory postsynaptic potential |
| 486 | lightcyan1 | 86 | 2.1e-03 | 1.000 | 6 | GO:0009410 | BP | response to xenobiotic stimulus |
| 487 | lightcyan1 | 86 | 2.6e-03 | 1.000 | 4 | GO:0006805 | BP | xenobiotic metabolic process |
| 488 | lightcyan1 | 86 | 4.0e-03 | 1.000 | 15 | GO:0005739 | CC | mitochondrion |
| 489 | lightcyan1 | 86 | 4.1e-03 | 1.000 | 2 | GO:0043153 | BP | entrainment of circadian clock by photoperiod |
| 490 | lightcyan1 | 86 | 4.1e-03 | 1.000 | 2 | GO:0046655 | BP | folic acid metabolic process |
| 491 | lightgreen | 163 | 2.8e-04 | 1.000 | 6 | GO:0097711 | BP | ciliary basal body-plasma membrane docking |
| 492 | lightgreen | 163 | 6.7e-04 | 1.000 | 2 | GO:0008440 | MF | inositol-1,4,5-trisphosphate 3-kinase activity |
| 493 | lightgreen | 163 | 9.3e-04 | 1.000 | 16 | GO:0005815 | CC | microtubule organizing center |
| 494 | lightgreen | 163 | 1.7e-03 | 1.000 | 2 | GO:0016321 | BP | female meiosis chromosome segregation |
| 495 | lightgreen | 163 | 2.4e-03 | 1.000 | 12 | GO:0005813 | CC | centrosome |
| 496 | lightgreen | 163 | 2.7e-03 | 1.000 | 8 | GO:0044839 | BP | cell cycle G2/M phase transition |
| 497 | lightgreen | 163 | 2.9e-03 | 1.000 | 13 | GO:0044770 | BP | cell cycle phase transition |
| 498 | lightgreen | 163 | 4.2e-03 | 1.000 | 32 | GO:0016740 | MF | transferase activity |
| 499 | lightgreen | 163 | 4.2e-03 | 1.000 | 7 | GO:0032886 | BP | regulation of microtubule-based process |
| 500 | lightgreen | 163 | 4.4e-03 | 1.000 | 20 | GO:0015630 | CC | microtubule cytoskeleton |
| 501 | lightpink3 | 48 | 3.0e-05 | 0.540 | 2 | GO:0000309 | MF | nicotinamide-nucleotide adenylyltransferase activity |
| 502 | lightpink3 | 48 | 6.0e-05 | 1.000 | 2 | GO:0004515 | MF | nicotinate-nucleotide adenylyltransferase activity |
| 503 | lightpink3 | 48 | 3.2e-04 | 1.000 | 3 | GO:0009435 | BP | NAD biosynthetic process |
| 504 | lightpink3 | 48 | 3.9e-04 | 1.000 | 3 | GO:0019829 | MF | cation-transporting ATPase activity |
| 505 | lightpink3 | 48 | 4.2e-04 | 1.000 | 3 | GO:0042625 | MF | ATPase coupled ion transmembrane transporter activity |
| 506 | lightpink3 | 48 | 9.2e-04 | 1.000 | 3 | GO:0019674 | BP | NAD metabolic process |
| 507 | lightpink3 | 48 | 1.2e-03 | 1.000 | 2 | GO:0070566 | MF | adenylyltransferase activity |
| 508 | lightpink3 | 48 | 1.3e-03 | 1.000 | 8 | GO:0015075 | MF | ion transmembrane transporter activity |
| 509 | lightpink3 | 48 | 2.0e-03 | 1.000 | 2 | GO:0046961 | MF | proton-transporting ATPase activity, rotational mechanism |
| 510 | lightpink3 | 48 | 2.6e-03 | 1.000 | 3 | GO:0042626 | MF | ATPase activity, coupled to transmembrane movement of substances |
| 511 | lightpink4 | 65 | 1.1e-04 | 1.000 | 2 | GO:0019732 | BP | antifungal humoral response |
| 512 | lightpink4 | 65 | 1.1e-04 | 1.000 | 2 | GO:0061760 | BP | antifungal innate immune response |
| 513 | lightpink4 | 65 | 3.2e-03 | 1.000 | 2 | GO:0016342 | CC | catenin complex |
| 514 | lightpink4 | 65 | 4.2e-03 | 1.000 | 1 | GO:0001543 | BP | ovarian follicle rupture |
| 515 | lightpink4 | 65 | 4.2e-03 | 1.000 | 1 | GO:0001809 | BP | positive regulation of type IV hypersensitivity |
| 516 | lightpink4 | 65 | 4.2e-03 | 1.000 | 1 | GO:0002380 | BP | immunoglobulin secretion involved in immune response |
| 517 | lightpink4 | 65 | 4.2e-03 | 1.000 | 1 | GO:0006392 | BP | transcription elongation from mitochondrial promoter |
| 518 | lightpink4 | 65 | 4.2e-03 | 1.000 | 1 | GO:0042418 | BP | epinephrine biosynthetic process |
| 519 | lightpink4 | 65 | 4.2e-03 | 1.000 | 1 | GO:0050652 | BP | dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process |
| 520 | lightpink4 | 65 | 4.2e-03 | 1.000 | 1 | GO:0061763 | BP | multivesicular body-lysosome fusion |
| 521 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:0003167 | BP | atrioventricular bundle cell differentiation |
| 522 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:0009789 | BP | positive regulation of abscisic acid-activated signaling pathway |
| 523 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:1990839 | BP | response to endothelin |
| 524 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:1990859 | BP | cellular response to endothelin |
| 525 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:0005914 | CC | spot adherens junction |
| 526 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:0017177 | CC | glucosidase II complex |
| 527 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:0001135 | MF | RNA polymerase II transcription regulator recruiting activity |
| 528 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:0008903 | MF | hydroxypyruvate isomerase activity |
| 529 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:0033919 | MF | glucan 1,3-alpha-glucosidase activity |
| 530 | lightslateblue | 39 | 2.6e-03 | 1.000 | 1 | GO:0070191 | MF | methionine-R-sulfoxide reductase activity |
| 531 | lightsteelblue | 50 | 4.4e-04 | 1.000 | 6 | GO:0006913 | BP | nucleocytoplasmic transport |
| 532 | lightsteelblue | 50 | 4.5e-04 | 1.000 | 6 | GO:0051169 | BP | nuclear transport |
| 533 | lightsteelblue | 50 | 1.4e-03 | 1.000 | 2 | GO:0048745 | BP | smooth muscle tissue development |
| 534 | lightsteelblue | 50 | 3.0e-03 | 1.000 | 12 | GO:1902531 | BP | regulation of intracellular signal transduction |
| 535 | lightsteelblue | 50 | 3.2e-03 | 1.000 | 3 | GO:0007006 | BP | mitochondrial membrane organization |
| 536 | lightsteelblue | 50 | 3.3e-03 | 1.000 | 1 | GO:0021757 | BP | caudate nucleus development |
| 537 | lightsteelblue | 50 | 3.3e-03 | 1.000 | 1 | GO:0021758 | BP | putamen development |
| 538 | lightsteelblue | 50 | 3.3e-03 | 1.000 | 1 | GO:0032023 | BP | trypsinogen activation |
| 539 | lightsteelblue | 50 | 3.3e-03 | 1.000 | 1 | GO:0035499 | BP | carnosine biosynthetic process |
| 540 | lightsteelblue | 50 | 3.3e-03 | 1.000 | 1 | GO:0071464 | BP | cellular response to hydrostatic pressure |
| 541 | lightsteelblue1 | 87 | 1.9e-04 | 1.000 | 6 | GO:0006986 | BP | response to unfolded protein |
| 542 | lightsteelblue1 | 87 | 3.1e-04 | 1.000 | 4 | GO:0036498 | BP | IRE1-mediated unfolded protein response |
| 543 | lightsteelblue1 | 87 | 3.5e-04 | 1.000 | 5 | GO:0030968 | BP | endoplasmic reticulum unfolded protein response |
| 544 | lightsteelblue1 | 87 | 4.7e-04 | 1.000 | 3 | GO:0046875 | MF | ephrin receptor binding |
| 545 | lightsteelblue1 | 87 | 5.8e-04 | 1.000 | 5 | GO:0034620 | BP | cellular response to unfolded protein |
| 546 | lightsteelblue1 | 87 | 6.5e-04 | 1.000 | 3 | GO:1900026 | BP | positive regulation of substrate adhesion-dependent cell spreading |
| 547 | lightsteelblue1 | 87 | 7.1e-04 | 1.000 | 2 | GO:1901201 | BP | regulation of extracellular matrix assembly |
| 548 | lightsteelblue1 | 87 | 1.2e-03 | 1.000 | 13 | GO:0000902 | BP | cell morphogenesis |
| 549 | lightsteelblue1 | 87 | 1.2e-03 | 1.000 | 5 | GO:0035967 | BP | cellular response to topologically incorrect protein |
| 550 | lightsteelblue1 | 87 | 1.8e-03 | 1.000 | 3 | GO:1900024 | BP | regulation of substrate adhesion-dependent cell spreading |
| 551 | lightyellow | 139 | 4.9e-04 | 1.000 | 2 | GO:0006344 | BP | maintenance of chromatin silencing |
| 552 | lightyellow | 139 | 1.2e-03 | 1.000 | 2 | GO:0019673 | BP | GDP-mannose metabolic process |
| 553 | lightyellow | 139 | 2.2e-03 | 1.000 | 2 | GO:0034058 | BP | endosomal vesicle fusion |
| 554 | lightyellow | 139 | 3.1e-03 | 1.000 | 3 | GO:0030547 | MF | receptor inhibitor activity |
| 555 | lightyellow | 139 | 4.3e-03 | 1.000 | 2 | GO:0007288 | BP | sperm axoneme assembly |
| 556 | lightyellow | 139 | 4.3e-03 | 1.000 | 2 | GO:2000009 | BP | negative regulation of protein localization to cell surface |
| 557 | lightyellow | 139 | 4.3e-03 | 1.000 | 2 | GO:0000340 | MF | RNA 7-methylguanosine cap binding |
| 558 | lightyellow | 139 | 4.7e-03 | 1.000 | 4 | GO:0030838 | BP | positive regulation of actin filament polymerization |
| 559 | lightyellow | 139 | 5.2e-03 | 1.000 | 2 | GO:0060077 | CC | inhibitory synapse |
| 560 | lightyellow | 139 | 5.3e-03 | 1.000 | 5 | GO:0035567 | BP | non-canonical Wnt signaling pathway |
| 561 | magenta | 274 | 9.8e-04 | 1.000 | 2 | GO:0000306 | CC | extrinsic component of vacuolar membrane |
| 562 | magenta | 274 | 1.2e-03 | 1.000 | 4 | GO:0035883 | BP | enteroendocrine cell differentiation |
| 563 | magenta | 274 | 1.9e-03 | 1.000 | 3 | GO:0050998 | MF | nitric-oxide synthase binding |
| 564 | magenta | 274 | 1.9e-03 | 1.000 | 2 | GO:0061470 | BP | T follicular helper cell differentiation |
| 565 | magenta | 274 | 2.1e-03 | 1.000 | 10 | GO:0006403 | BP | RNA localization |
| 566 | magenta | 274 | 2.3e-03 | 1.000 | 3 | GO:0045056 | BP | transcytosis |
| 567 | magenta | 274 | 2.8e-03 | 1.000 | 3 | GO:0050951 | BP | sensory perception of temperature stimulus |
| 568 | magenta | 274 | 2.8e-03 | 1.000 | 3 | GO:0086013 | BP | membrane repolarization during cardiac muscle cell action potential |
| 569 | magenta | 274 | 2.9e-03 | 1.000 | 4 | GO:0086009 | BP | membrane repolarization |
| 570 | magenta | 274 | 2.9e-03 | 1.000 | 9 | GO:0050658 | BP | RNA transport |
| 571 | magenta4 | 43 | 3.7e-04 | 1.000 | 4 | GO:0000070 | BP | mitotic sister chromatid segregation |
| 572 | magenta4 | 43 | 4.0e-04 | 1.000 | 3 | GO:1905818 | BP | regulation of chromosome separation |
| 573 | magenta4 | 43 | 8.5e-04 | 1.000 | 3 | GO:0033045 | BP | regulation of sister chromatid segregation |
| 574 | magenta4 | 43 | 8.6e-04 | 1.000 | 4 | GO:0000819 | BP | sister chromatid segregation |
| 575 | magenta4 | 43 | 9.6e-04 | 1.000 | 3 | GO:0051304 | BP | chromosome separation |
| 576 | magenta4 | 43 | 1.1e-03 | 1.000 | 2 | GO:0005680 | CC | anaphase-promoting complex |
| 577 | magenta4 | 43 | 1.7e-03 | 1.000 | 3 | GO:0051983 | BP | regulation of chromosome segregation |
| 578 | magenta4 | 43 | 2.3e-03 | 1.000 | 4 | GO:0098813 | BP | nuclear chromosome segregation |
| 579 | magenta4 | 43 | 2.6e-03 | 1.000 | 1 | GO:0003363 | BP | lamellipodium assembly involved in ameboidal cell migration |
| 580 | magenta4 | 43 | 2.6e-03 | 1.000 | 1 | GO:0055048 | BP | anastral spindle assembly |
| 581 | maroon | 74 | 1.1e-03 | 1.000 | 3 | GO:0046456 | BP | icosanoid biosynthetic process |
| 582 | maroon | 74 | 1.8e-03 | 1.000 | 5 | GO:0017157 | BP | regulation of exocytosis |
| 583 | maroon | 74 | 2.4e-03 | 1.000 | 2 | GO:0035461 | BP | vitamin transmembrane transport |
| 584 | maroon | 74 | 2.7e-03 | 1.000 | 2 | GO:0019370 | BP | leukotriene biosynthetic process |
| 585 | maroon | 74 | 3.1e-03 | 1.000 | 2 | GO:0033630 | BP | positive regulation of cell adhesion mediated by integrin |
| 586 | maroon | 74 | 3.2e-03 | 1.000 | 3 | GO:0050871 | BP | positive regulation of B cell activation |
| 587 | maroon | 74 | 4.9e-03 | 1.000 | 1 | GO:0002926 | BP | tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation |
| 588 | maroon | 74 | 4.9e-03 | 1.000 | 1 | GO:0006452 | BP | translational frameshifting |
| 589 | maroon | 74 | 4.9e-03 | 1.000 | 1 | GO:0010509 | BP | polyamine homeostasis |
| 590 | maroon | 74 | 4.9e-03 | 1.000 | 1 | GO:0045401 | BP | positive regulation of interleukin-3 biosynthetic process |
| 591 | mediumorchid | 57 | 7.7e-04 | 1.000 | 2 | GO:1904996 | BP | positive regulation of leukocyte adhesion to vascular endothelial cell |
| 592 | mediumorchid | 57 | 2.3e-03 | 1.000 | 2 | GO:0001516 | BP | prostaglandin biosynthetic process |
| 593 | mediumorchid | 57 | 3.2e-03 | 1.000 | 4 | GO:0071478 | BP | cellular response to radiation |
| 594 | mediumorchid | 57 | 3.8e-03 | 1.000 | 1 | GO:0015878 | BP | biotin transport |
| 595 | mediumorchid | 57 | 3.8e-03 | 1.000 | 1 | GO:0015887 | BP | pantothenate transmembrane transport |
| 596 | mediumorchid | 57 | 3.8e-03 | 1.000 | 1 | GO:0030421 | BP | defecation |
| 597 | mediumorchid | 57 | 3.8e-03 | 1.000 | 1 | GO:0034120 | BP | positive regulation of erythrocyte aggregation |
| 598 | mediumorchid | 57 | 3.8e-03 | 1.000 | 1 | GO:0061078 | BP | positive regulation of prostaglandin secretion involved in immune response |
| 599 | mediumorchid | 57 | 3.8e-03 | 1.000 | 1 | GO:0072703 | BP | cellular response to methyl methanesulfonate |
| 600 | mediumorchid | 57 | 3.8e-03 | 1.000 | 1 | GO:1901384 | BP | positive regulation of chorionic trophoblast cell proliferation |
| 601 | mediumpurple1 | 37 | 6.7e-04 | 1.000 | 2 | GO:1904754 | BP | positive regulation of vascular associated smooth muscle cell migration |
| 602 | mediumpurple1 | 37 | 9.3e-04 | 1.000 | 5 | GO:0006790 | BP | sulfur compound metabolic process |
| 603 | mediumpurple1 | 37 | 1.5e-03 | 1.000 | 2 | GO:0071280 | BP | cellular response to copper ion |
| 604 | mediumpurple1 | 37 | 2.4e-03 | 1.000 | 1 | GO:0034760 | BP | negative regulation of iron ion transmembrane transport |
| 605 | mediumpurple1 | 37 | 2.4e-03 | 1.000 | 1 | GO:1903353 | BP | regulation of nucleus organization |
| 606 | mediumpurple1 | 37 | 2.4e-03 | 1.000 | 1 | GO:0016784 | MF | 3-mercaptopyruvate sulfurtransferase activity |
| 607 | mediumpurple1 | 37 | 2.9e-03 | 1.000 | 2 | GO:0014911 | BP | positive regulation of smooth muscle cell migration |
| 608 | mediumpurple1 | 37 | 2.9e-03 | 1.000 | 2 | GO:0060043 | BP | regulation of cardiac muscle cell proliferation |
| 609 | mediumpurple1 | 37 | 2.9e-03 | 1.000 | 3 | GO:0001889 | BP | liver development |
| 610 | mediumpurple1 | 37 | 3.1e-03 | 1.000 | 2 | GO:0046688 | BP | response to copper ion |
| 611 | mediumpurple2 | 61 | 1.0e-04 | 1.000 | 8 | GO:0043025 | CC | neuronal cell body |
| 612 | mediumpurple2 | 61 | 2.2e-04 | 1.000 | 2 | GO:0043203 | CC | axon hillock |
| 613 | mediumpurple2 | 61 | 2.5e-04 | 1.000 | 8 | GO:0044297 | CC | cell body |
| 614 | mediumpurple2 | 61 | 2.5e-04 | 1.000 | 3 | GO:0031111 | BP | negative regulation of microtubule polymerization or depolymerization |
| 615 | mediumpurple2 | 61 | 5.3e-04 | 1.000 | 3 | GO:0002931 | BP | response to ischemia |
| 616 | mediumpurple2 | 61 | 5.7e-04 | 1.000 | 3 | GO:0047496 | BP | vesicle transport along microtubule |
| 617 | mediumpurple2 | 61 | 6.5e-04 | 1.000 | 2 | GO:0002162 | MF | dystroglycan binding |
| 618 | mediumpurple2 | 61 | 1.5e-03 | 1.000 | 2 | GO:0099524 | CC | postsynaptic cytosol |
| 619 | mediumpurple2 | 61 | 1.5e-03 | 1.000 | 2 | GO:0047555 | MF | 3’,5’-cyclic-GMP phosphodiesterase activity |
| 620 | mediumpurple2 | 61 | 1.5e-03 | 1.000 | 7 | GO:0045860 | BP | positive regulation of protein kinase activity |
| 621 | mediumpurple3 | 91 | 4.8e-06 | 0.087 | 5 | GO:0061647 | BP | histone H3-K9 modification |
| 622 | mediumpurple3 | 91 | 1.7e-05 | 0.310 | 6 | GO:0034968 | BP | histone lysine methylation |
| 623 | mediumpurple3 | 91 | 1.8e-05 | 0.320 | 6 | GO:0006304 | BP | DNA modification |
| 624 | mediumpurple3 | 91 | 2.4e-05 | 0.440 | 6 | GO:0018022 | BP | peptidyl-lysine methylation |
| 625 | mediumpurple3 | 91 | 5.5e-05 | 0.990 | 6 | GO:0016571 | BP | histone methylation |
| 626 | mediumpurple3 | 91 | 1.1e-04 | 1.000 | 2 | GO:1990037 | CC | Lewy body core |
| 627 | mediumpurple3 | 91 | 1.5e-04 | 1.000 | 4 | GO:0051568 | BP | histone H3-K4 methylation |
| 628 | mediumpurple3 | 91 | 1.8e-04 | 1.000 | 6 | GO:0006479 | BP | protein methylation |
| 629 | mediumpurple3 | 91 | 1.9e-04 | 1.000 | 3 | GO:0051570 | BP | regulation of histone H3-K9 methylation |
| 630 | mediumpurple3 | 91 | 2.6e-04 | 1.000 | 4 | GO:0031060 | BP | regulation of histone methylation |
| 631 | mediumpurple4 | 42 | 6.3e-04 | 1.000 | 2 | GO:0004970 | MF | ionotropic glutamate receptor activity |
| 632 | mediumpurple4 | 42 | 1.2e-03 | 1.000 | 2 | GO:0035235 | BP | ionotropic glutamate receptor signaling pathway |
| 633 | mediumpurple4 | 42 | 1.4e-03 | 1.000 | 2 | GO:0008066 | MF | glutamate receptor activity |
| 634 | mediumpurple4 | 42 | 2.4e-03 | 1.000 | 2 | GO:0006658 | BP | phosphatidylserine metabolic process |
| 635 | mediumpurple4 | 42 | 2.8e-03 | 1.000 | 2 | GO:2000310 | BP | regulation of NMDA receptor activity |
| 636 | mediumpurple4 | 42 | 2.9e-03 | 1.000 | 1 | GO:0018964 | BP | propylene metabolic process |
| 637 | mediumpurple4 | 42 | 2.9e-03 | 1.000 | 1 | GO:0090251 | BP | protein localization involved in establishment of planar polarity |
| 638 | mediumpurple4 | 42 | 2.9e-03 | 1.000 | 1 | GO:0002059 | MF | thymine binding |
| 639 | mediumpurple4 | 42 | 2.9e-03 | 1.000 | 1 | GO:0004157 | MF | dihydropyrimidinase activity |
| 640 | mediumpurple4 | 42 | 2.9e-03 | 1.000 | 1 | GO:0071890 | MF | bicarbonate binding |
| 641 | midnightblue | 225 | 1.3e-05 | 0.240 | 3 | GO:0005534 | MF | galactose binding |
| 642 | midnightblue | 225 | 4.4e-05 | 0.810 | 4 | GO:0004029 | MF | aldehyde dehydrogenase (NAD) activity |
| 643 | midnightblue | 225 | 1.1e-04 | 1.000 | 5 | GO:0016620 | MF | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor |
| 644 | midnightblue | 225 | 6.7e-04 | 1.000 | 2 | GO:0010133 | BP | proline catabolic process to glutamate |
| 645 | midnightblue | 225 | 6.7e-04 | 1.000 | 2 | GO:0019470 | BP | 4-hydroxyproline catabolic process |
| 646 | midnightblue | 225 | 1.1e-03 | 1.000 | 3 | GO:0048185 | MF | activin binding |
| 647 | midnightblue | 225 | 1.3e-03 | 1.000 | 2 | GO:0006562 | BP | proline catabolic process |
| 648 | midnightblue | 225 | 1.3e-03 | 1.000 | 2 | GO:0060355 | BP | positive regulation of cell adhesion molecule production |
| 649 | midnightblue | 225 | 1.3e-03 | 1.000 | 3 | GO:0043649 | BP | dicarboxylic acid catabolic process |
| 650 | midnightblue | 225 | 1.5e-03 | 1.000 | 6 | GO:0043648 | BP | dicarboxylic acid metabolic process |
| 651 | navajowhite1 | 49 | 1.7e-05 | 0.320 | 4 | GO:0005871 | CC | kinesin complex |
| 652 | navajowhite1 | 49 | 2.9e-04 | 1.000 | 2 | GO:0051574 | BP | positive regulation of histone H3-K9 methylation |
| 653 | navajowhite1 | 49 | 3.4e-04 | 1.000 | 3 | GO:0047496 | BP | vesicle transport along microtubule |
| 654 | navajowhite1 | 49 | 6.6e-04 | 1.000 | 4 | GO:0005875 | CC | microtubule associated complex |
| 655 | navajowhite1 | 49 | 6.7e-04 | 1.000 | 2 | GO:0007100 | BP | mitotic centrosome separation |
| 656 | navajowhite1 | 49 | 7.9e-04 | 1.000 | 2 | GO:0051299 | BP | centrosome separation |
| 657 | navajowhite1 | 49 | 8.5e-04 | 1.000 | 5 | GO:0007018 | BP | microtubule-based movement |
| 658 | navajowhite1 | 49 | 1.2e-03 | 1.000 | 4 | GO:0021543 | BP | pallium development |
| 659 | navajowhite1 | 49 | 1.2e-03 | 1.000 | 2 | GO:0021516 | BP | dorsal spinal cord development |
| 660 | navajowhite1 | 49 | 1.5e-03 | 1.000 | 3 | GO:0072384 | BP | organelle transport along microtubule |
| 661 | navajowhite2 | 72 | 4.5e-04 | 1.000 | 2 | GO:0036449 | CC | microtubule minus-end |
| 662 | navajowhite2 | 72 | 1.2e-03 | 1.000 | 2 | GO:0015867 | BP | ATP transport |
| 663 | navajowhite2 | 72 | 1.2e-03 | 1.000 | 2 | GO:0043560 | MF | insulin receptor substrate binding |
| 664 | navajowhite2 | 72 | 1.4e-03 | 1.000 | 3 | GO:0046854 | BP | phosphatidylinositol phosphorylation |
| 665 | navajowhite2 | 72 | 1.7e-03 | 1.000 | 2 | GO:0030506 | MF | ankyrin binding |
| 666 | navajowhite2 | 72 | 2.2e-03 | 1.000 | 3 | GO:0046834 | BP | lipid phosphorylation |
| 667 | navajowhite2 | 72 | 2.2e-03 | 1.000 | 2 | GO:0010592 | BP | positive regulation of lamellipodium assembly |
| 668 | navajowhite2 | 72 | 2.5e-03 | 1.000 | 2 | GO:0015865 | BP | purine nucleotide transport |
| 669 | navajowhite2 | 72 | 2.5e-03 | 1.000 | 2 | GO:0015868 | BP | purine ribonucleotide transport |
| 670 | navajowhite2 | 72 | 2.8e-03 | 1.000 | 7 | GO:0015711 | BP | organic anion transport |
| 671 | orange | 122 | 2.0e-03 | 1.000 | 4 | GO:0006112 | BP | energy reserve metabolic process |
| 672 | orange | 122 | 2.4e-03 | 1.000 | 3 | GO:0005978 | BP | glycogen biosynthetic process |
| 673 | orange | 122 | 2.7e-03 | 1.000 | 2 | GO:0018095 | BP | protein polyglutamylation |
| 674 | orange | 122 | 2.7e-03 | 1.000 | 2 | GO:0016580 | CC | Sin3 complex |
| 675 | orange | 122 | 3.9e-03 | 1.000 | 2 | GO:0043031 | BP | negative regulation of macrophage activation |
| 676 | orange | 122 | 4.0e-03 | 1.000 | 5 | GO:1990845 | BP | adaptive thermogenesis |
| 677 | orange | 122 | 4.6e-03 | 1.000 | 2 | GO:0070822 | CC | Sin3-type complex |
| 678 | orange | 122 | 7.9e-03 | 1.000 | 1 | GO:0006424 | BP | glutamyl-tRNA aminoacylation |
| 679 | orange | 122 | 7.9e-03 | 1.000 | 1 | GO:0006589 | BP | octopamine biosynthetic process |
| 680 | orange | 122 | 7.9e-03 | 1.000 | 1 | GO:0045819 | BP | positive regulation of glycogen catabolic process |
| 681 | orangered1 | 38 | 2.4e-03 | 1.000 | 2 | GO:0035909 | BP | aorta morphogenesis |
| 682 | orangered1 | 38 | 2.6e-03 | 1.000 | 1 | GO:0001315 | BP | age-dependent response to reactive oxygen species |
| 683 | orangered1 | 38 | 2.6e-03 | 1.000 | 1 | GO:0003069 | BP | acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure |
| 684 | orangered1 | 38 | 2.6e-03 | 1.000 | 1 | GO:1904550 | BP | response to arachidonic acid |
| 685 | orangered1 | 38 | 2.6e-03 | 1.000 | 1 | GO:1905667 | BP | negative regulation of protein localization to endosome |
| 686 | orangered1 | 38 | 2.6e-03 | 1.000 | 1 | GO:1905932 | BP | positive regulation of vascular smooth muscle cell differentiation involved in phenotypic switching |
| 687 | orangered1 | 38 | 2.6e-03 | 1.000 | 1 | GO:0030379 | MF | neurotensin receptor activity, non-G protein-coupled |
| 688 | orangered1 | 38 | 3.4e-03 | 1.000 | 3 | GO:0030518 | BP | intracellular steroid hormone receptor signaling pathway |
| 689 | orangered1 | 38 | 4.5e-03 | 1.000 | 2 | GO:0050681 | MF | androgen receptor binding |
| 690 | orangered1 | 38 | 5.3e-03 | 1.000 | 1 | GO:0001306 | BP | age-dependent response to oxidative stress |
| 691 | orangered3 | 54 | 1.2e-03 | 1.000 | 6 | GO:0046982 | MF | protein heterodimerization activity |
| 692 | orangered3 | 54 | 2.0e-03 | 1.000 | 10 | GO:0046983 | MF | protein dimerization activity |
| 693 | orangered3 | 54 | 2.7e-03 | 1.000 | 2 | GO:0003887 | MF | DNA-directed DNA polymerase activity |
| 694 | orangered3 | 54 | 3.5e-03 | 1.000 | 9 | GO:1901698 | BP | response to nitrogen compound |
| 695 | orangered3 | 54 | 3.5e-03 | 1.000 | 1 | GO:0034148 | BP | negative regulation of toll-like receptor 5 signaling pathway |
| 696 | orangered3 | 54 | 3.5e-03 | 1.000 | 1 | GO:0038115 | BP | chemokine (C-C motif) ligand 19 signaling pathway |
| 697 | orangered3 | 54 | 3.5e-03 | 1.000 | 1 | GO:0042431 | BP | indole metabolic process |
| 698 | orangered3 | 54 | 3.5e-03 | 1.000 | 1 | GO:0048178 | BP | negative regulation of hepatocyte growth factor biosynthetic process |
| 699 | orangered3 | 54 | 3.5e-03 | 1.000 | 1 | GO:0070429 | BP | negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway |
| 700 | orangered3 | 54 | 3.5e-03 | 1.000 | 1 | GO:0072573 | BP | tolerance induction to lipopolysaccharide |
| 701 | orangered4 | 92 | 3.7e-05 | 0.670 | 2 | GO:0003835 | MF | beta-galactoside alpha-2,6-sialyltransferase activity |
| 702 | orangered4 | 92 | 1.0e-03 | 1.000 | 2 | GO:1903423 | BP | positive regulation of synaptic vesicle recycling |
| 703 | orangered4 | 92 | 1.3e-03 | 1.000 | 2 | GO:0042532 | BP | negative regulation of tyrosine phosphorylation of STAT protein |
| 704 | orangered4 | 92 | 2.3e-03 | 1.000 | 2 | GO:0005639 | CC | integral component of nuclear inner membrane |
| 705 | orangered4 | 92 | 3.2e-03 | 1.000 | 2 | GO:0072112 | BP | glomerular visceral epithelial cell differentiation |
| 706 | orangered4 | 92 | 3.5e-03 | 1.000 | 3 | GO:0061077 | BP | chaperone-mediated protein folding |
| 707 | orangered4 | 92 | 3.8e-03 | 1.000 | 5 | GO:0051896 | BP | regulation of protein kinase B signaling |
| 708 | orangered4 | 92 | 4.2e-03 | 1.000 | 2 | GO:0046426 | BP | negative regulation of JAK-STAT cascade |
| 709 | orangered4 | 92 | 4.2e-03 | 1.000 | 2 | GO:0072010 | BP | glomerular epithelium development |
| 710 | orangered4 | 92 | 4.2e-03 | 1.000 | 2 | GO:0043186 | CC | P granule |
| 711 | paleturquoise | 113 | 2.0e-03 | 1.000 | 2 | GO:0072542 | MF | protein phosphatase activator activity |
| 712 | paleturquoise | 113 | 2.9e-03 | 1.000 | 4 | GO:2000379 | BP | positive regulation of reactive oxygen species metabolic process |
| 713 | paleturquoise | 113 | 3.0e-03 | 1.000 | 5 | GO:0008360 | BP | regulation of cell shape |
| 714 | paleturquoise | 113 | 3.0e-03 | 1.000 | 2 | GO:1900452 | BP | regulation of long-term synaptic depression |
| 715 | paleturquoise | 113 | 3.6e-03 | 1.000 | 2 | GO:0006450 | BP | regulation of translational fidelity |
| 716 | paleturquoise | 113 | 3.6e-03 | 1.000 | 2 | GO:0004707 | MF | MAP kinase activity |
| 717 | paleturquoise | 113 | 3.6e-03 | 1.000 | 2 | GO:0019211 | MF | phosphatase activator activity |
| 718 | paleturquoise | 113 | 6.3e-03 | 1.000 | 2 | GO:0032930 | BP | positive regulation of superoxide anion generation |
| 719 | paleturquoise | 113 | 7.2e-03 | 1.000 | 2 | GO:0045663 | BP | positive regulation of myoblast differentiation |
| 720 | paleturquoise | 113 | 7.6e-03 | 1.000 | 1 | GO:0003195 | BP | tricuspid valve formation |
| 721 | palevioletred1 | 27 | 9.0e-04 | 1.000 | 5 | GO:0044089 | BP | positive regulation of cellular component biogenesis |
| 722 | palevioletred1 | 27 | 1.8e-03 | 1.000 | 1 | GO:0001808 | BP | negative regulation of type IV hypersensitivity |
| 723 | palevioletred1 | 27 | 1.8e-03 | 1.000 | 1 | GO:0032788 | BP | saturated monocarboxylic acid metabolic process |
| 724 | palevioletred1 | 27 | 1.8e-03 | 1.000 | 1 | GO:0032789 | BP | unsaturated monocarboxylic acid metabolic process |
| 725 | palevioletred1 | 27 | 2.4e-03 | 1.000 | 5 | GO:0030036 | BP | actin cytoskeleton organization |
| 726 | palevioletred1 | 27 | 2.5e-03 | 1.000 | 4 | GO:0007015 | BP | actin filament organization |
| 727 | palevioletred1 | 27 | 3.0e-03 | 1.000 | 2 | GO:2000272 | BP | negative regulation of signaling receptor activity |
| 728 | palevioletred1 | 27 | 3.6e-03 | 1.000 | 1 | GO:0043006 | BP | activation of phospholipase A2 activity by calcium-mediated signaling |
| 729 | palevioletred1 | 27 | 3.6e-03 | 1.000 | 1 | GO:0001607 | MF | neuromedin U receptor activity |
| 730 | palevioletred1 | 27 | 3.6e-03 | 1.000 | 1 | GO:0004778 | MF | succinyl-CoA hydrolase activity |
| 731 | palevioletred2 | 48 | 6.4e-04 | 1.000 | 3 | GO:0030173 | CC | integral component of Golgi membrane |
| 732 | palevioletred2 | 48 | 7.5e-04 | 1.000 | 3 | GO:0031228 | CC | intrinsic component of Golgi membrane |
| 733 | palevioletred2 | 48 | 2.3e-03 | 1.000 | 4 | GO:0031301 | CC | integral component of organelle membrane |
| 734 | palevioletred2 | 48 | 2.6e-03 | 1.000 | 2 | GO:0005640 | CC | nuclear outer membrane |
| 735 | palevioletred2 | 48 | 3.1e-03 | 1.000 | 2 | GO:0046875 | MF | ephrin receptor binding |
| 736 | palevioletred2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0018009 | BP | N-terminal peptidyl-L-cysteine N-palmitoylation |
| 737 | palevioletred2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0021509 | BP | roof plate formation |
| 738 | palevioletred2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0090321 | BP | positive regulation of chylomicron remnant clearance |
| 739 | palevioletred2 | 48 | 3.2e-03 | 1.000 | 1 | GO:0101030 | BP | tRNA-guanine transglycosylation |
| 740 | palevioletred2 | 48 | 3.2e-03 | 1.000 | 1 | GO:1900383 | BP | regulation of synaptic plasticity by receptor localization to synapse |
| 741 | palevioletred3 | 77 | 2.6e-04 | 1.000 | 2 | GO:0071169 | BP | establishment of protein localization to chromatin |
| 742 | palevioletred3 | 77 | 1.7e-03 | 1.000 | 2 | GO:0070831 | BP | basement membrane assembly |
| 743 | palevioletred3 | 77 | 2.3e-03 | 1.000 | 8 | GO:0000228 | CC | nuclear chromosome |
| 744 | palevioletred3 | 77 | 2.9e-03 | 1.000 | 11 | GO:0005694 | CC | chromosome |
| 745 | palevioletred3 | 77 | 3.8e-03 | 1.000 | 2 | GO:2000738 | BP | positive regulation of stem cell differentiation |
| 746 | palevioletred3 | 77 | 4.0e-03 | 1.000 | 3 | GO:0000792 | CC | heterochromatin |
| 747 | palevioletred3 | 77 | 4.2e-03 | 1.000 | 2 | GO:0005721 | CC | pericentric heterochromatin |
| 748 | palevioletred3 | 77 | 4.8e-03 | 1.000 | 7 | GO:0000785 | CC | chromatin |
| 749 | palevioletred3 | 77 | 5.1e-03 | 1.000 | 2 | GO:0071711 | BP | basement membrane organization |
| 750 | palevioletred3 | 77 | 5.1e-03 | 1.000 | 1 | GO:0018315 | BP | molybdenum incorporation into molybdenum-molybdopterin complex |
| 751 | pink | 321 | 4.0e-05 | 0.730 | 9 | GO:0097327 | BP | response to antineoplastic agent |
| 752 | pink | 321 | 2.4e-04 | 1.000 | 4 | GO:0051571 | BP | positive regulation of histone H3-K4 methylation |
| 753 | pink | 321 | 2.7e-04 | 1.000 | 10 | GO:0005088 | MF | Ras guanyl-nucleotide exchange factor activity |
| 754 | pink | 321 | 4.6e-04 | 1.000 | 2 | GO:1901315 | BP | negative regulation of histone H2A K63-linked ubiquitination |
| 755 | pink | 321 | 4.6e-04 | 1.000 | 2 | GO:0061711 | MF | N(6)-L-threonylcarbamoyladenine synthase activity |
| 756 | pink | 321 | 5.1e-04 | 1.000 | 3 | GO:0003266 | BP | regulation of secondary heart field cardioblast proliferation |
| 757 | pink | 321 | 7.6e-04 | 1.000 | 7 | GO:0005089 | MF | Rho guanyl-nucleotide exchange factor activity |
| 758 | pink | 321 | 1.1e-03 | 1.000 | 7 | GO:0060021 | BP | roof of mouth development |
| 759 | pink | 321 | 1.1e-03 | 1.000 | 3 | GO:0051852 | BP | disruption by host of symbiont cells |
| 760 | pink | 321 | 1.4e-03 | 1.000 | 4 | GO:0051569 | BP | regulation of histone H3-K4 methylation |
| 761 | pink4 | 37 | 1.1e-04 | 1.000 | 2 | GO:2000562 | BP | negative regulation of CD4-positive, alpha-beta T cell proliferation |
| 762 | pink4 | 37 | 1.1e-04 | 1.000 | 2 | GO:2001181 | BP | positive regulation of interleukin-10 secretion |
| 763 | pink4 | 37 | 1.8e-04 | 1.000 | 2 | GO:0046642 | BP | negative regulation of alpha-beta T cell proliferation |
| 764 | pink4 | 37 | 2.3e-04 | 1.000 | 2 | GO:0046007 | BP | negative regulation of activated T cell proliferation |
| 765 | pink4 | 37 | 2.8e-04 | 1.000 | 2 | GO:0070234 | BP | positive regulation of T cell apoptotic process |
| 766 | pink4 | 37 | 2.8e-04 | 1.000 | 2 | GO:0072608 | BP | interleukin-10 secretion |
| 767 | pink4 | 37 | 4.5e-04 | 1.000 | 2 | GO:0070230 | BP | positive regulation of lymphocyte apoptotic process |
| 768 | pink4 | 37 | 7.6e-04 | 1.000 | 2 | GO:0002507 | BP | tolerance induction |
| 769 | pink4 | 37 | 1.4e-03 | 1.000 | 2 | GO:2000108 | BP | positive regulation of leukocyte apoptotic process |
| 770 | pink4 | 37 | 1.4e-03 | 1.000 | 2 | GO:2000515 | BP | negative regulation of CD4-positive, alpha-beta T cell activation |
| 771 | plum | 60 | 1.3e-04 | 1.000 | 2 | GO:1904753 | BP | negative regulation of vascular associated smooth muscle cell migration |
| 772 | plum | 60 | 5.6e-04 | 1.000 | 3 | GO:0045661 | BP | regulation of myoblast differentiation |
| 773 | plum | 60 | 6.3e-04 | 1.000 | 20 | GO:0031325 | BP | positive regulation of cellular metabolic process |
| 774 | plum | 60 | 6.7e-04 | 1.000 | 21 | GO:0009893 | BP | positive regulation of metabolic process |
| 775 | plum | 60 | 6.8e-04 | 1.000 | 3 | GO:0016459 | CC | myosin complex |
| 776 | plum | 60 | 9.7e-04 | 1.000 | 2 | GO:0055012 | BP | ventricular cardiac muscle cell differentiation |
| 777 | plum | 60 | 9.7e-04 | 1.000 | 2 | GO:0001056 | MF | RNA polymerase III activity |
| 778 | plum | 60 | 1.0e-03 | 1.000 | 27 | GO:0097159 | MF | organic cyclic compound binding |
| 779 | plum | 60 | 1.1e-03 | 1.000 | 4 | GO:0007519 | BP | skeletal muscle tissue development |
| 780 | plum | 60 | 1.3e-03 | 1.000 | 4 | GO:0060538 | BP | skeletal muscle organ development |
| 781 | plum1 | 90 | 9.2e-05 | 1.000 | 7 | GO:0002064 | BP | epithelial cell development |
| 782 | plum1 | 90 | 2.2e-04 | 1.000 | 2 | GO:0004366 | MF | glycerol-3-phosphate O-acyltransferase activity |
| 783 | plum1 | 90 | 2.2e-04 | 1.000 | 2 | GO:0102420 | MF | sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity |
| 784 | plum1 | 90 | 2.2e-04 | 1.000 | 4 | GO:0048306 | MF | calcium-dependent protein binding |
| 785 | plum1 | 90 | 5.4e-04 | 1.000 | 2 | GO:0006573 | BP | valine metabolic process |
| 786 | plum1 | 90 | 7.2e-04 | 1.000 | 3 | GO:0003382 | BP | epithelial cell morphogenesis |
| 787 | plum1 | 90 | 7.2e-04 | 1.000 | 3 | GO:0043394 | MF | proteoglycan binding |
| 788 | plum1 | 90 | 1.1e-03 | 1.000 | 11 | GO:0030855 | BP | epithelial cell differentiation |
| 789 | plum1 | 90 | 1.3e-03 | 1.000 | 2 | GO:0001867 | BP | complement activation, lectin pathway |
| 790 | plum1 | 90 | 2.8e-03 | 1.000 | 2 | GO:0016024 | BP | CDP-diacylglycerol biosynthetic process |
| 791 | plum2 | 76 | 2.7e-03 | 1.000 | 2 | GO:0010801 | BP | negative regulation of peptidyl-threonine phosphorylation |
| 792 | plum2 | 76 | 5.2e-03 | 1.000 | 1 | GO:0007402 | BP | ganglion mother cell fate determination |
| 793 | plum2 | 76 | 5.2e-03 | 1.000 | 1 | GO:0048874 | BP | host-mediated regulation of intestinal microbiota composition |
| 794 | plum2 | 76 | 5.2e-03 | 1.000 | 1 | GO:0060118 | BP | vestibular receptor cell development |
| 795 | plum2 | 76 | 5.2e-03 | 1.000 | 1 | GO:0070292 | BP | N-acylphosphatidylethanolamine metabolic process |
| 796 | plum2 | 76 | 5.2e-03 | 1.000 | 1 | GO:0099546 | BP | protein catabolic process, modulating synaptic transmission |
| 797 | plum2 | 76 | 5.2e-03 | 1.000 | 1 | GO:0038038 | CC | G protein-coupled receptor homodimeric complex |
| 798 | plum2 | 76 | 5.2e-03 | 1.000 | 1 | GO:0032029 | MF | myosin tail binding |
| 799 | plum2 | 76 | 5.2e-03 | 1.000 | 1 | GO:0033791 | MF | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity |
| 800 | plum2 | 76 | 5.2e-03 | 1.000 | 1 | GO:0046316 | MF | gluconokinase activity |
| 801 | plum3 | 59 | 4.1e-04 | 1.000 | 2 | GO:0008401 | MF | retinoic acid 4-hydroxylase activity |
| 802 | plum3 | 59 | 6.5e-04 | 1.000 | 2 | GO:0032769 | BP | negative regulation of monooxygenase activity |
| 803 | plum3 | 59 | 1.1e-03 | 1.000 | 2 | GO:0008391 | MF | arachidonic acid monooxygenase activity |
| 804 | plum3 | 59 | 1.1e-03 | 1.000 | 2 | GO:0008392 | MF | arachidonic acid epoxygenase activity |
| 805 | plum3 | 59 | 1.6e-03 | 1.000 | 3 | GO:0031397 | BP | negative regulation of protein ubiquitination |
| 806 | plum3 | 59 | 1.7e-03 | 1.000 | 2 | GO:0019373 | BP | epoxygenase P450 pathway |
| 807 | plum3 | 59 | 1.7e-03 | 1.000 | 2 | GO:0099092 | CC | postsynaptic density, intracellular component |
| 808 | plum3 | 59 | 1.7e-03 | 1.000 | 2 | GO:0004622 | MF | lysophospholipase activity |
| 809 | plum3 | 59 | 2.4e-03 | 1.000 | 2 | GO:0051354 | BP | negative regulation of oxidoreductase activity |
| 810 | plum3 | 59 | 2.4e-03 | 1.000 | 2 | GO:0099091 | CC | postsynaptic specialization, intracellular component |
| 811 | plum4 | 27 | 1.2e-04 | 1.000 | 4 | GO:0006479 | BP | protein methylation |
| 812 | plum4 | 27 | 2.7e-04 | 1.000 | 3 | GO:0008276 | MF | protein methyltransferase activity |
| 813 | plum4 | 27 | 6.4e-04 | 1.000 | 3 | GO:0034968 | BP | histone lysine methylation |
| 814 | plum4 | 27 | 7.7e-04 | 1.000 | 3 | GO:0018022 | BP | peptidyl-lysine methylation |
| 815 | plum4 | 27 | 1.2e-03 | 1.000 | 2 | GO:0045737 | BP | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
| 816 | plum4 | 27 | 1.2e-03 | 1.000 | 3 | GO:0016571 | BP | histone methylation |
| 817 | plum4 | 27 | 1.4e-03 | 1.000 | 2 | GO:1904031 | BP | positive regulation of cyclin-dependent protein kinase activity |
| 818 | plum4 | 27 | 1.9e-03 | 1.000 | 1 | GO:2001165 | BP | positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues |
| 819 | plum4 | 27 | 1.9e-03 | 1.000 | 1 | GO:0004747 | MF | ribokinase activity |
| 820 | plum4 | 27 | 1.9e-03 | 1.000 | 1 | GO:0036373 | MF | L-fucose mutarotase activity |
| 821 | purple | 281 | 3.5e-04 | 1.000 | 2 | GO:0048388 | BP | endosomal lumen acidification |
| 822 | purple | 281 | 5.8e-04 | 1.000 | 7 | GO:0007631 | BP | feeding behavior |
| 823 | purple | 281 | 7.0e-04 | 1.000 | 3 | GO:0010649 | BP | regulation of cell communication by electrical coupling |
| 824 | purple | 281 | 7.9e-04 | 1.000 | 4 | GO:0035925 | MF | mRNA 3’-UTR AU-rich region binding |
| 825 | purple | 281 | 9.4e-04 | 1.000 | 4 | GO:0017091 | MF | AU-rich element binding |
| 826 | purple | 281 | 1.0e-03 | 1.000 | 2 | GO:0061047 | BP | positive regulation of branching involved in lung morphogenesis |
| 827 | purple | 281 | 1.0e-03 | 1.000 | 2 | GO:0150018 | BP | basal dendrite development |
| 828 | purple | 281 | 1.0e-03 | 1.000 | 2 | GO:0150019 | BP | basal dendrite morphogenesis |
| 829 | purple | 281 | 1.0e-03 | 1.000 | 2 | GO:0150020 | BP | basal dendrite arborization |
| 830 | purple | 281 | 1.6e-03 | 1.000 | 3 | GO:0006646 | BP | phosphatidylethanolamine biosynthetic process |
| 831 | red | 608 | 2.7e-04 | 1.000 | 4 | GO:0010857 | MF | calcium-dependent protein kinase activity |
| 832 | red | 608 | 6.0e-04 | 1.000 | 3 | GO:0048241 | BP | epinephrine transport |
| 833 | red | 608 | 6.0e-04 | 1.000 | 3 | GO:0048242 | BP | epinephrine secretion |
| 834 | red | 608 | 1.5e-03 | 1.000 | 6 | GO:2000273 | BP | positive regulation of signaling receptor activity |
| 835 | red | 608 | 1.6e-03 | 1.000 | 2 | GO:0005724 | CC | nuclear telomeric heterochromatin |
| 836 | red | 608 | 1.6e-03 | 1.000 | 2 | GO:0001004 | MF | RNA polymerase III transcription regulator recruiting activity |
| 837 | red | 608 | 2.8e-03 | 1.000 | 5 | GO:0043236 | MF | laminin binding |
| 838 | red | 608 | 3.0e-03 | 1.000 | 14 | GO:0006399 | BP | tRNA metabolic process |
| 839 | red | 608 | 3.1e-03 | 1.000 | 3 | GO:0010510 | BP | regulation of acetyl-CoA biosynthetic process from pyruvate |
| 840 | red | 608 | 3.1e-03 | 1.000 | 3 | GO:0009931 | MF | calcium-dependent protein serine/threonine kinase activity |
| 841 | royalblue | 155 | 2.8e-04 | 1.000 | 2 | GO:0051036 | BP | regulation of endosome size |
| 842 | royalblue | 155 | 1.4e-03 | 1.000 | 2 | GO:0075713 | BP | establishment of integrated proviral latency |
| 843 | royalblue | 155 | 1.9e-03 | 1.000 | 2 | GO:0016078 | BP | tRNA catabolic process |
| 844 | royalblue | 155 | 1.9e-03 | 1.000 | 2 | GO:0019043 | BP | establishment of viral latency |
| 845 | royalblue | 155 | 2.3e-03 | 1.000 | 5 | GO:0004540 | MF | ribonuclease activity |
| 846 | royalblue | 155 | 4.0e-03 | 1.000 | 4 | GO:0005758 | CC | mitochondrial intermembrane space |
| 847 | royalblue | 155 | 4.1e-03 | 1.000 | 2 | GO:0022841 | MF | potassium ion leak channel activity |
| 848 | royalblue | 155 | 4.8e-03 | 1.000 | 3 | GO:0002204 | BP | somatic recombination of immunoglobulin genes involved in immune response |
| 849 | royalblue | 155 | 4.8e-03 | 1.000 | 3 | GO:0045190 | BP | isotype switching |
| 850 | royalblue | 155 | 4.9e-03 | 1.000 | 4 | GO:0005089 | MF | Rho guanyl-nucleotide exchange factor activity |
| 851 | saddlebrown | 118 | 4.2e-04 | 1.000 | 5 | GO:0051261 | BP | protein depolymerization |
| 852 | saddlebrown | 118 | 8.6e-04 | 1.000 | 4 | GO:0043242 | BP | negative regulation of protein complex disassembly |
| 853 | saddlebrown | 118 | 9.9e-04 | 1.000 | 3 | GO:0051693 | BP | actin filament capping |
| 854 | saddlebrown | 118 | 1.1e-03 | 1.000 | 2 | GO:0008541 | CC | proteasome regulatory particle, lid subcomplex |
| 855 | saddlebrown | 118 | 1.2e-03 | 1.000 | 3 | GO:0030835 | BP | negative regulation of actin filament depolymerization |
| 856 | saddlebrown | 118 | 1.3e-03 | 1.000 | 4 | GO:1901879 | BP | regulation of protein depolymerization |
| 857 | saddlebrown | 118 | 1.5e-03 | 1.000 | 2 | GO:0045792 | BP | negative regulation of cell size |
| 858 | saddlebrown | 118 | 1.9e-03 | 1.000 | 2 | GO:0006828 | BP | manganese ion transport |
| 859 | saddlebrown | 118 | 2.3e-03 | 1.000 | 3 | GO:0030834 | BP | regulation of actin filament depolymerization |
| 860 | saddlebrown | 118 | 2.3e-03 | 1.000 | 2 | GO:0016783 | MF | sulfurtransferase activity |
| 861 | salmon | 238 | 9.2e-05 | 1.000 | 4 | GO:0032026 | BP | response to magnesium ion |
| 862 | salmon | 238 | 1.3e-04 | 1.000 | 3 | GO:0051901 | BP | positive regulation of mitochondrial depolarization |
| 863 | salmon | 238 | 2.3e-04 | 1.000 | 4 | GO:0007398 | BP | ectoderm development |
| 864 | salmon | 238 | 2.4e-04 | 1.000 | 2 | GO:0006649 | BP | phospholipid transfer to membrane |
| 865 | salmon | 238 | 1.8e-03 | 1.000 | 3 | GO:0005184 | MF | neuropeptide hormone activity |
| 866 | salmon | 238 | 2.1e-03 | 1.000 | 4 | GO:0003254 | BP | regulation of membrane depolarization |
| 867 | salmon | 238 | 2.2e-03 | 1.000 | 3 | GO:0051349 | BP | positive regulation of lyase activity |
| 868 | salmon | 238 | 2.4e-03 | 1.000 | 2 | GO:0010757 | BP | negative regulation of plasminogen activation |
| 869 | salmon | 238 | 2.4e-03 | 1.000 | 2 | GO:0071286 | BP | cellular response to magnesium ion |
| 870 | salmon | 238 | 2.6e-03 | 1.000 | 4 | GO:0070169 | BP | positive regulation of biomineral tissue development |
| 871 | salmon1 | 28 | 1.6e-03 | 1.000 | 5 | GO:0071407 | BP | cellular response to organic cyclic compound |
| 872 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0010849 | BP | regulation of proton-transporting ATPase activity, rotational mechanism |
| 873 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0032618 | BP | interleukin-15 production |
| 874 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0032738 | BP | positive regulation of interleukin-15 production |
| 875 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0035665 | BP | TIRAP-dependent toll-like receptor 4 signaling pathway |
| 876 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0036316 | BP | SREBP-SCAP complex retention in endoplasmic reticulum |
| 877 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:1901303 | BP | negative regulation of cargo loading into COPII-coated vesicle |
| 878 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0005753 | CC | mitochondrial proton-transporting ATP synthase complex |
| 879 | salmon1 | 28 | 1.9e-03 | 1.000 | 1 | GO:0045259 | CC | proton-transporting ATP synthase complex |
| 880 | salmon1 | 28 | 3.3e-03 | 1.000 | 2 | GO:0042771 | BP | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| 881 | salmon2 | 48 | 2.2e-04 | 1.000 | 2 | GO:0036066 | BP | protein O-linked fucosylation |
| 882 | salmon2 | 48 | 5.2e-04 | 1.000 | 5 | GO:0030258 | BP | lipid modification |
| 883 | salmon2 | 48 | 6.7e-04 | 1.000 | 2 | GO:0030259 | BP | lipid glycosylation |
| 884 | salmon2 | 48 | 1.5e-03 | 1.000 | 2 | GO:0036065 | BP | fucosylation |
| 885 | salmon2 | 48 | 1.5e-03 | 1.000 | 2 | GO:0060713 | BP | labyrinthine layer morphogenesis |
| 886 | salmon2 | 48 | 1.7e-03 | 1.000 | 3 | GO:0006094 | BP | gluconeogenesis |
| 887 | salmon2 | 48 | 1.9e-03 | 1.000 | 3 | GO:0019319 | BP | hexose biosynthetic process |
| 888 | salmon2 | 48 | 2.5e-03 | 1.000 | 2 | GO:0060669 | BP | embryonic placenta morphogenesis |
| 889 | salmon2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0002470 | BP | plasmacytoid dendritic cell antigen processing and presentation |
| 890 | salmon2 | 48 | 3.3e-03 | 1.000 | 1 | GO:0006843 | BP | mitochondrial citrate transmembrane transport |
| 891 | salmon4 | 76 | 1.7e-03 | 1.000 | 2 | GO:0000346 | CC | transcription export complex |
| 892 | salmon4 | 76 | 5.1e-03 | 1.000 | 1 | GO:0032889 | BP | regulation of vacuole fusion, non-autophagic |
| 893 | salmon4 | 76 | 5.1e-03 | 1.000 | 1 | GO:0048264 | BP | determination of ventral identity |
| 894 | salmon4 | 76 | 5.1e-03 | 1.000 | 1 | GO:0061534 | BP | gamma-aminobutyric acid secretion, neurotransmission |
| 895 | salmon4 | 76 | 5.1e-03 | 1.000 | 1 | GO:1903638 | BP | positive regulation of protein import into mitochondrial outer membrane |
| 896 | salmon4 | 76 | 5.1e-03 | 1.000 | 1 | GO:1903645 | BP | negative regulation of chaperone-mediated protein folding |
| 897 | salmon4 | 76 | 5.1e-03 | 1.000 | 1 | GO:0003979 | MF | UDP-glucose 6-dehydrogenase activity |
| 898 | salmon4 | 76 | 5.1e-03 | 1.000 | 1 | GO:0008890 | MF | glycine C-acetyltransferase activity |
| 899 | salmon4 | 76 | 5.1e-03 | 1.000 | 1 | GO:1990275 | MF | preribosome binding |
| 900 | salmon4 | 76 | 6.2e-03 | 1.000 | 3 | GO:0006400 | BP | tRNA modification |
| 901 | sienna3 | 98 | 2.6e-04 | 1.000 | 2 | GO:0061156 | BP | pulmonary artery morphogenesis |
| 902 | sienna3 | 98 | 1.0e-03 | 1.000 | 5 | GO:0048565 | BP | digestive tract development |
| 903 | sienna3 | 98 | 1.0e-03 | 1.000 | 3 | GO:0048048 | BP | embryonic eye morphogenesis |
| 904 | sienna3 | 98 | 1.0e-03 | 1.000 | 3 | GO:0048566 | BP | embryonic digestive tract development |
| 905 | sienna3 | 98 | 1.6e-03 | 1.000 | 5 | GO:0055123 | BP | digestive system development |
| 906 | sienna3 | 98 | 2.6e-03 | 1.000 | 8 | GO:0010256 | BP | endomembrane system organization |
| 907 | sienna3 | 98 | 2.7e-03 | 1.000 | 3 | GO:0016830 | MF | carbon-carbon lyase activity |
| 908 | sienna3 | 98 | 2.8e-03 | 1.000 | 2 | GO:0033004 | BP | negative regulation of mast cell activation |
| 909 | sienna3 | 98 | 3.3e-03 | 1.000 | 2 | GO:0030479 | CC | actin cortical patch |
| 910 | sienna3 | 98 | 3.8e-03 | 1.000 | 2 | GO:0006089 | BP | lactate metabolic process |
| 911 | sienna4 | 39 | 1.4e-04 | 1.000 | 2 | GO:0086036 | BP | regulation of cardiac muscle cell membrane potential |
| 912 | sienna4 | 39 | 1.2e-03 | 1.000 | 12 | GO:0000166 | MF | nucleotide binding |
| 913 | sienna4 | 39 | 1.2e-03 | 1.000 | 2 | GO:0017134 | MF | fibroblast growth factor binding |
| 914 | sienna4 | 39 | 2.4e-03 | 1.000 | 3 | GO:0016779 | MF | nucleotidyltransferase activity |
| 915 | sienna4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0034059 | BP | response to anoxia |
| 916 | sienna4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0045715 | BP | negative regulation of low-density lipoprotein particle receptor biosynthetic process |
| 917 | sienna4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0052066 | BP | entry of symbiont into host cell by promotion of host phagocytosis |
| 918 | sienna4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0070899 | BP | mitochondrial tRNA wobble uridine modification |
| 919 | sienna4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0071454 | BP | cellular response to anoxia |
| 920 | sienna4 | 39 | 2.6e-03 | 1.000 | 1 | GO:0034683 | CC | integrin alphav-beta3 complex |
| 921 | skyblue | 119 | 7.4e-05 | 1.000 | 3 | GO:0045651 | BP | positive regulation of macrophage differentiation |
| 922 | skyblue | 119 | 2.0e-04 | 1.000 | 3 | GO:0045649 | BP | regulation of macrophage differentiation |
| 923 | skyblue | 119 | 2.0e-03 | 1.000 | 3 | GO:0030225 | BP | macrophage differentiation |
| 924 | skyblue | 119 | 2.1e-03 | 1.000 | 2 | GO:0097428 | BP | protein maturation by iron-sulfur cluster transfer |
| 925 | skyblue | 119 | 3.4e-03 | 1.000 | 5 | GO:0016331 | BP | morphogenesis of embryonic epithelium |
| 926 | skyblue | 119 | 3.8e-03 | 1.000 | 2 | GO:0098831 | CC | presynaptic active zone cytoplasmic component |
| 927 | skyblue | 119 | 4.6e-03 | 1.000 | 3 | GO:0002763 | BP | positive regulation of myeloid leukocyte differentiation |
| 928 | skyblue | 119 | 4.9e-03 | 1.000 | 3 | GO:0051148 | BP | negative regulation of muscle cell differentiation |
| 929 | skyblue | 119 | 5.2e-03 | 1.000 | 5 | GO:0021915 | BP | neural tube development |
| 930 | skyblue | 119 | 5.6e-03 | 1.000 | 3 | GO:0007029 | BP | endoplasmic reticulum organization |
| 931 | skyblue1 | 63 | 1.2e-03 | 1.000 | 3 | GO:0016627 | MF | oxidoreductase activity, acting on the CH-CH group of donors |
| 932 | skyblue1 | 63 | 1.5e-03 | 1.000 | 3 | GO:0030173 | CC | integral component of Golgi membrane |
| 933 | skyblue1 | 63 | 1.7e-03 | 1.000 | 3 | GO:0031228 | CC | intrinsic component of Golgi membrane |
| 934 | skyblue1 | 63 | 2.6e-03 | 1.000 | 2 | GO:0032982 | CC | myosin filament |
| 935 | skyblue1 | 63 | 4.1e-03 | 1.000 | 3 | GO:0008585 | BP | female gonad development |
| 936 | skyblue1 | 63 | 4.2e-03 | 1.000 | 3 | GO:0005179 | MF | hormone activity |
| 937 | skyblue1 | 63 | 4.2e-03 | 1.000 | 1 | GO:0006436 | BP | tryptophanyl-tRNA aminoacylation |
| 938 | skyblue1 | 63 | 4.2e-03 | 1.000 | 1 | GO:0019046 | BP | release from viral latency |
| 939 | skyblue1 | 63 | 4.2e-03 | 1.000 | 1 | GO:0060734 | BP | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation |
| 940 | skyblue1 | 63 | 4.2e-03 | 1.000 | 1 | GO:0070183 | BP | mitochondrial tryptophanyl-tRNA aminoacylation |
| 941 | skyblue2 | 54 | 1.9e-04 | 1.000 | 2 | GO:0007196 | BP | adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway |
| 942 | skyblue2 | 54 | 6.9e-04 | 1.000 | 2 | GO:0007216 | BP | G protein-coupled glutamate receptor signaling pathway |
| 943 | skyblue2 | 54 | 2.1e-03 | 1.000 | 2 | GO:0008066 | MF | glutamate receptor activity |
| 944 | skyblue2 | 54 | 2.1e-03 | 1.000 | 6 | GO:0098793 | CC | presynapse |
| 945 | skyblue2 | 54 | 3.6e-03 | 1.000 | 1 | GO:0050902 | BP | leukocyte adhesive activation |
| 946 | skyblue2 | 54 | 3.6e-03 | 1.000 | 1 | GO:0051545 | BP | negative regulation of elastin biosynthetic process |
| 947 | skyblue2 | 54 | 3.6e-03 | 1.000 | 1 | GO:1900075 | BP | positive regulation of neuromuscular synaptic transmission |
| 948 | skyblue2 | 54 | 3.6e-03 | 1.000 | 1 | GO:1903699 | BP | tarsal gland development |
| 949 | skyblue2 | 54 | 3.6e-03 | 1.000 | 1 | GO:1903709 | BP | uterine gland development |
| 950 | skyblue2 | 54 | 3.6e-03 | 1.000 | 1 | GO:1990697 | BP | protein depalmitoleylation |
| 951 | skyblue3 | 89 | 1.3e-04 | 1.000 | 3 | GO:0043162 | BP | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
| 952 | skyblue3 | 89 | 7.2e-04 | 1.000 | 2 | GO:0000813 | CC | ESCRT I complex |
| 953 | skyblue3 | 89 | 2.2e-03 | 1.000 | 2 | GO:0043023 | MF | ribosomal large subunit binding |
| 954 | skyblue3 | 89 | 2.6e-03 | 1.000 | 2 | GO:0070593 | BP | dendrite self-avoidance |
| 955 | skyblue3 | 89 | 2.6e-03 | 1.000 | 2 | GO:0070986 | BP | left/right axis specification |
| 956 | skyblue3 | 89 | 3.1e-03 | 1.000 | 2 | GO:0043024 | MF | ribosomal small subunit binding |
| 957 | skyblue3 | 89 | 3.8e-03 | 1.000 | 4 | GO:0043021 | MF | ribonucleoprotein complex binding |
| 958 | skyblue3 | 89 | 4.0e-03 | 1.000 | 18 | GO:0010557 | BP | positive regulation of macromolecule biosynthetic process |
| 959 | skyblue3 | 89 | 4.5e-03 | 1.000 | 2 | GO:0044305 | CC | calyx of Held |
| 960 | skyblue3 | 89 | 4.5e-03 | 1.000 | 2 | GO:0034458 | MF | 3’-5’ RNA helicase activity |
| 961 | skyblue4 | 42 | 2.1e-05 | 0.390 | 2 | GO:0070336 | MF | flap-structured DNA binding |
| 962 | skyblue4 | 42 | 8.1e-04 | 1.000 | 3 | GO:0021675 | BP | nerve development |
| 963 | skyblue4 | 42 | 1.5e-03 | 1.000 | 7 | GO:0098655 | BP | cation transmembrane transport |
| 964 | skyblue4 | 42 | 1.7e-03 | 1.000 | 2 | GO:0001835 | BP | blastocyst hatching |
| 965 | skyblue4 | 42 | 2.0e-03 | 1.000 | 7 | GO:0030001 | BP | metal ion transport |
| 966 | skyblue4 | 42 | 2.1e-03 | 1.000 | 8 | GO:0006812 | BP | cation transport |
| 967 | skyblue4 | 42 | 2.7e-03 | 1.000 | 1 | GO:0021572 | BP | rhombomere 6 development |
| 968 | skyblue4 | 42 | 2.7e-03 | 1.000 | 1 | GO:0030264 | BP | nuclear fragmentation involved in apoptotic nuclear change |
| 969 | skyblue4 | 42 | 2.7e-03 | 1.000 | 1 | GO:0090122 | BP | cholesterol ester hydrolysis involved in cholesterol transport |
| 970 | skyblue4 | 42 | 2.7e-03 | 1.000 | 1 | GO:1902443 | BP | negative regulation of ripoptosome assembly involved in necroptotic process |
| 971 | steelblue | 114 | 3.6e-05 | 0.650 | 4 | GO:0043548 | MF | phosphatidylinositol 3-kinase binding |
| 972 | steelblue | 114 | 5.8e-05 | 1.000 | 2 | GO:0090065 | BP | regulation of production of siRNA involved in RNA interference |
| 973 | steelblue | 114 | 6.4e-05 | 1.000 | 6 | GO:1904659 | BP | glucose transmembrane transport |
| 974 | steelblue | 114 | 8.1e-05 | 1.000 | 6 | GO:0008645 | BP | hexose transmembrane transport |
| 975 | steelblue | 114 | 1.0e-04 | 1.000 | 6 | GO:0034219 | BP | carbohydrate transmembrane transport |
| 976 | steelblue | 114 | 1.6e-04 | 1.000 | 27 | GO:0048468 | BP | cell development |
| 977 | steelblue | 114 | 1.7e-04 | 1.000 | 2 | GO:0050689 | BP | negative regulation of defense response to virus by host |
| 978 | steelblue | 114 | 2.1e-04 | 1.000 | 7 | GO:1901215 | BP | negative regulation of neuron death |
| 979 | steelblue | 114 | 3.6e-04 | 1.000 | 5 | GO:1901888 | BP | regulation of cell junction assembly |
| 980 | steelblue | 114 | 3.8e-04 | 1.000 | 3 | GO:0050321 | MF | tau-protein kinase activity |
| 981 | tan | 248 | 8.3e-04 | 1.000 | 2 | GO:0044752 | BP | response to human chorionic gonadotropin |
| 982 | tan | 248 | 1.6e-03 | 1.000 | 2 | GO:0046952 | BP | ketone body catabolic process |
| 983 | tan | 248 | 2.1e-03 | 1.000 | 6 | GO:0071013 | CC | catalytic step 2 spliceosome |
| 984 | tan | 248 | 2.3e-03 | 1.000 | 16 | GO:0006397 | BP | mRNA processing |
| 985 | tan | 248 | 3.6e-03 | 1.000 | 4 | GO:0045744 | BP | negative regulation of G protein-coupled receptor signaling pathway |
| 986 | tan | 248 | 4.0e-03 | 1.000 | 2 | GO:0006189 | BP | ‘de novo’ IMP biosynthetic process |
| 987 | tan | 248 | 4.0e-03 | 1.000 | 2 | GO:0032696 | BP | negative regulation of interleukin-13 production |
| 988 | tan | 248 | 4.1e-03 | 1.000 | 12 | GO:0000398 | BP | mRNA splicing, via spliceosome |
| 989 | tan | 248 | 4.3e-03 | 1.000 | 4 | GO:0001917 | CC | photoreceptor inner segment |
| 990 | tan | 248 | 4.4e-03 | 1.000 | 12 | GO:0000375 | BP | RNA splicing, via transesterification reactions |
| 991 | tan4 | 27 | 8.5e-04 | 1.000 | 2 | GO:0017075 | MF | syntaxin-1 binding |
| 992 | tan4 | 27 | 1.4e-03 | 1.000 | 2 | GO:0030547 | MF | receptor inhibitor activity |
| 993 | tan4 | 27 | 1.7e-03 | 1.000 | 3 | GO:0010469 | BP | regulation of signaling receptor activity |
| 994 | tan4 | 27 | 1.7e-03 | 1.000 | 1 | GO:0014064 | BP | positive regulation of serotonin secretion |
| 995 | tan4 | 27 | 1.7e-03 | 1.000 | 1 | GO:0090067 | BP | regulation of thalamus size |
| 996 | tan4 | 27 | 1.7e-03 | 1.000 | 1 | GO:1905596 | BP | negative regulation of low-density lipoprotein particle receptor binding |
| 997 | tan4 | 27 | 1.7e-03 | 1.000 | 1 | GO:1905598 | BP | negative regulation of low-density lipoprotein receptor activity |
| 998 | tan4 | 27 | 1.7e-03 | 1.000 | 1 | GO:1905601 | BP | negative regulation of receptor-mediated endocytosis involved in cholesterol transport |
| 999 | tan4 | 27 | 1.7e-03 | 1.000 | 1 | GO:0019811 | MF | cocaine binding |
| 1000 | tan4 | 27 | 1.7e-03 | 1.000 | 1 | GO:0061798 | MF | GTP 3’,8’-cyclase activity |
| 1001 | thistle | 47 | 1.3e-04 | 1.000 | 2 | GO:0030854 | BP | positive regulation of granulocyte differentiation |
| 1002 | thistle | 47 | 1.3e-03 | 1.000 | 4 | GO:0032388 | BP | positive regulation of intracellular transport |
| 1003 | thistle | 47 | 1.6e-03 | 1.000 | 2 | GO:0070286 | BP | axonemal dynein complex assembly |
| 1004 | thistle | 47 | 3.0e-03 | 1.000 | 1 | GO:0010121 | BP | arginine catabolic process to proline via ornithine |
| 1005 | thistle | 47 | 3.0e-03 | 1.000 | 1 | GO:0019544 | BP | arginine catabolic process to glutamate |
| 1006 | thistle | 47 | 3.0e-03 | 1.000 | 1 | GO:0016590 | CC | ACF complex |
| 1007 | thistle | 47 | 3.0e-03 | 1.000 | 1 | GO:0004587 | MF | ornithine-oxo-acid transaminase activity |
| 1008 | thistle | 47 | 3.1e-03 | 1.000 | 2 | GO:0030851 | BP | granulocyte differentiation |
| 1009 | thistle | 47 | 3.1e-03 | 1.000 | 2 | GO:0060285 | BP | cilium-dependent cell motility |
| 1010 | thistle | 47 | 3.9e-03 | 1.000 | 3 | GO:0090316 | BP | positive regulation of intracellular protein transport |
| 1011 | thistle1 | 81 | 9.3e-04 | 1.000 | 10 | GO:0007600 | BP | sensory perception |
| 1012 | thistle1 | 81 | 4.9e-03 | 1.000 | 2 | GO:0002052 | BP | positive regulation of neuroblast proliferation |
| 1013 | thistle1 | 81 | 5.3e-03 | 1.000 | 1 | GO:0001899 | BP | negative regulation of cytolysis by symbiont of host cells |
| 1014 | thistle1 | 81 | 5.3e-03 | 1.000 | 1 | GO:0007634 | BP | optokinetic behavior |
| 1015 | thistle1 | 81 | 5.3e-03 | 1.000 | 1 | GO:0035352 | BP | NAD transmembrane transport |
| 1016 | thistle1 | 81 | 5.3e-03 | 1.000 | 1 | GO:0046745 | BP | viral capsid secondary envelopment |
| 1017 | thistle1 | 81 | 5.3e-03 | 1.000 | 1 | GO:0072740 | BP | cellular response to anisomycin |
| 1018 | thistle1 | 81 | 5.3e-03 | 1.000 | 1 | GO:1900111 | BP | positive regulation of histone H3-K9 dimethylation |
| 1019 | thistle1 | 81 | 5.3e-03 | 1.000 | 1 | GO:1904271 | BP | L-proline import across plasma membrane |
| 1020 | thistle1 | 81 | 5.3e-03 | 1.000 | 1 | GO:0016935 | CC | glycine-gated chloride channel complex |
| 1021 | thistle2 | 75 | 2.2e-04 | 1.000 | 2 | GO:0005638 | CC | lamin filament |
| 1022 | thistle2 | 75 | 3.0e-04 | 1.000 | 3 | GO:0055090 | BP | acylglycerol homeostasis |
| 1023 | thistle2 | 75 | 3.0e-04 | 1.000 | 3 | GO:0070328 | BP | triglyceride homeostasis |
| 1024 | thistle2 | 75 | 4.5e-04 | 1.000 | 2 | GO:0006702 | BP | androgen biosynthetic process |
| 1025 | thistle2 | 75 | 4.5e-04 | 1.000 | 2 | GO:0071044 | BP | histone mRNA catabolic process |
| 1026 | thistle2 | 75 | 7.7e-04 | 1.000 | 2 | GO:0070508 | BP | cholesterol import |
| 1027 | thistle2 | 75 | 9.6e-04 | 1.000 | 2 | GO:0055091 | BP | phospholipid homeostasis |
| 1028 | thistle2 | 75 | 9.6e-04 | 1.000 | 2 | GO:0075522 | BP | IRES-dependent viral translational initiation |
| 1029 | thistle2 | 75 | 9.6e-04 | 1.000 | 2 | GO:0008035 | MF | high-density lipoprotein particle binding |
| 1030 | thistle2 | 75 | 1.2e-03 | 1.000 | 2 | GO:0005652 | CC | nuclear lamina |
| 1031 | thistle3 | 50 | 7.1e-05 | 1.000 | 3 | GO:0032228 | BP | regulation of synaptic transmission, GABAergic |
| 1032 | thistle3 | 50 | 1.5e-04 | 1.000 | 2 | GO:0032229 | BP | negative regulation of synaptic transmission, GABAergic |
| 1033 | thistle3 | 50 | 1.7e-04 | 1.000 | 3 | GO:0051932 | BP | synaptic transmission, GABAergic |
| 1034 | thistle3 | 50 | 1.4e-03 | 1.000 | 3 | GO:0051117 | MF | ATPase binding |
| 1035 | thistle3 | 50 | 2.6e-03 | 1.000 | 6 | GO:0000978 | MF | RNA polymerase II proximal promoter sequence-specific DNA binding |
| 1036 | thistle3 | 50 | 2.9e-03 | 1.000 | 7 | GO:0051640 | BP | organelle localization |
| 1037 | thistle3 | 50 | 3.0e-03 | 1.000 | 2 | GO:0018279 | BP | protein N-linked glycosylation via asparagine |
| 1038 | thistle3 | 50 | 3.0e-03 | 1.000 | 6 | GO:0000987 | MF | proximal promoter sequence-specific DNA binding |
| 1039 | thistle3 | 50 | 3.3e-03 | 1.000 | 1 | GO:0001928 | BP | regulation of exocyst assembly |
| 1040 | thistle3 | 50 | 3.3e-03 | 1.000 | 1 | GO:0040030 | BP | regulation of molecular function, epigenetic |
| 1041 | thistle4 | 31 | 3.5e-04 | 1.000 | 3 | GO:0000932 | CC | P-body |
| 1042 | thistle4 | 31 | 2.0e-03 | 1.000 | 1 | GO:0006540 | BP | glutamate decarboxylation to succinate |
| 1043 | thistle4 | 31 | 2.0e-03 | 1.000 | 1 | GO:1903721 | BP | positive regulation of I-kappaB phosphorylation |
| 1044 | thistle4 | 31 | 2.0e-03 | 1.000 | 1 | GO:1904905 | BP | negative regulation of endothelial cell-matrix adhesion via fibronectin |
| 1045 | thistle4 | 31 | 2.0e-03 | 1.000 | 1 | GO:0005590 | CC | collagen type VII trimer |
| 1046 | thistle4 | 31 | 2.0e-03 | 1.000 | 1 | GO:0090534 | CC | calcium ion-transporting ATPase complex |
| 1047 | thistle4 | 31 | 2.0e-03 | 1.000 | 1 | GO:0004351 | MF | glutamate decarboxylase activity |
| 1048 | thistle4 | 31 | 3.1e-03 | 1.000 | 2 | GO:0033628 | BP | regulation of cell adhesion mediated by integrin |
| 1049 | thistle4 | 31 | 4.0e-03 | 1.000 | 1 | GO:0009449 | BP | gamma-aminobutyric acid biosynthetic process |
| 1050 | thistle4 | 31 | 4.0e-03 | 1.000 | 1 | GO:0018352 | BP | protein-pyridoxal-5-phosphate linkage |
| 1051 | turquoise | 1444 | 6.6e-04 | 1.000 | 5 | GO:0070208 | BP | protein heterotrimerization |
| 1052 | turquoise | 1444 | 8.3e-04 | 1.000 | 3 | GO:0006391 | BP | transcription initiation from mitochondrial promoter |
| 1053 | turquoise | 1444 | 8.3e-04 | 1.000 | 3 | GO:0030906 | CC | retromer, cargo-selective complex |
| 1054 | turquoise | 1444 | 9.9e-04 | 1.000 | 4 | GO:1903003 | BP | positive regulation of protein deubiquitination |
| 1055 | turquoise | 1444 | 2.1e-03 | 1.000 | 5 | GO:0014889 | BP | muscle atrophy |
| 1056 | turquoise | 1444 | 2.1e-03 | 1.000 | 4 | GO:0044613 | CC | nuclear pore central transport channel |
| 1057 | turquoise | 1444 | 3.1e-03 | 1.000 | 3 | GO:0060510 | BP | type II pneumocyte differentiation |
| 1058 | turquoise | 1444 | 3.3e-03 | 1.000 | 5 | GO:0035458 | BP | cellular response to interferon-beta |
| 1059 | turquoise | 1444 | 3.3e-03 | 1.000 | 8 | GO:0032094 | BP | response to food |
| 1060 | turquoise | 1444 | 3.3e-03 | 1.000 | 9 | GO:0001974 | BP | blood vessel remodeling |
| 1061 | violet | 108 | 4.9e-04 | 1.000 | 2 | GO:0060718 | BP | chorionic trophoblast cell differentiation |
| 1062 | violet | 108 | 1.0e-03 | 1.000 | 2 | GO:0060717 | BP | chorion development |
| 1063 | violet | 108 | 1.0e-03 | 1.000 | 2 | GO:0061744 | BP | motor behavior |
| 1064 | violet | 108 | 1.4e-03 | 1.000 | 2 | GO:0006265 | BP | DNA topological change |
| 1065 | violet | 108 | 2.6e-03 | 1.000 | 3 | GO:0048156 | MF | tau protein binding |
| 1066 | violet | 108 | 3.7e-03 | 1.000 | 2 | GO:0033038 | MF | bitter taste receptor activity |
| 1067 | violet | 108 | 3.9e-03 | 1.000 | 5 | GO:0051099 | BP | positive regulation of binding |
| 1068 | violet | 108 | 4.3e-03 | 1.000 | 2 | GO:0030730 | BP | sequestering of triglyceride |
| 1069 | violet | 108 | 4.9e-03 | 1.000 | 2 | GO:0050765 | BP | negative regulation of phagocytosis |
| 1070 | violet | 108 | 4.9e-03 | 1.000 | 2 | GO:0030247 | MF | polysaccharide binding |
| 1071 | white | 119 | 1.0e-04 | 1.000 | 51 | GO:0005829 | CC | cytosol |
| 1072 | white | 119 | 5.8e-04 | 1.000 | 2 | GO:0035965 | BP | cardiolipin acyl-chain remodeling |
| 1073 | white | 119 | 8.6e-04 | 1.000 | 2 | GO:0036089 | BP | cleavage furrow formation |
| 1074 | white | 119 | 8.6e-04 | 1.000 | 2 | GO:1905274 | BP | regulation of modification of postsynaptic actin cytoskeleton |
| 1075 | white | 119 | 1.6e-03 | 1.000 | 2 | GO:0072710 | BP | response to hydroxyurea |
| 1076 | white | 119 | 1.6e-03 | 1.000 | 2 | GO:0099159 | BP | regulation of modification of postsynaptic structure |
| 1077 | white | 119 | 1.6e-03 | 1.000 | 2 | GO:1900122 | BP | positive regulation of receptor binding |
| 1078 | white | 119 | 2.5e-03 | 1.000 | 2 | GO:0017119 | CC | Golgi transport complex |
| 1079 | white | 119 | 2.8e-03 | 1.000 | 10 | GO:0010608 | BP | posttranscriptional regulation of gene expression |
| 1080 | white | 119 | 3.1e-03 | 1.000 | 2 | GO:0032048 | BP | cardiolipin metabolic process |
| 1081 | yellow | 709 | 4.0e-04 | 1.000 | 3 | GO:0015917 | BP | aminophospholipid transport |
| 1082 | yellow | 709 | 7.2e-04 | 1.000 | 21 | GO:0033673 | BP | negative regulation of kinase activity |
| 1083 | yellow | 709 | 1.9e-03 | 1.000 | 8 | GO:0043550 | BP | regulation of lipid kinase activity |
| 1084 | yellow | 709 | 1.9e-03 | 1.000 | 51 | GO:0043549 | BP | regulation of kinase activity |
| 1085 | yellow | 709 | 2.2e-03 | 1.000 | 2 | GO:0016340 | BP | calcium-dependent cell-matrix adhesion |
| 1086 | yellow | 709 | 2.2e-03 | 1.000 | 2 | GO:0035026 | BP | leading edge cell differentiation |
| 1087 | yellow | 709 | 2.2e-03 | 1.000 | 2 | GO:1905702 | BP | regulation of inhibitory synapse assembly |
| 1088 | yellow | 709 | 2.2e-03 | 1.000 | 2 | GO:1905704 | BP | positive regulation of inhibitory synapse assembly |
| 1089 | yellow | 709 | 2.2e-03 | 1.000 | 2 | GO:1990051 | BP | activation of protein kinase C activity |
| 1090 | yellow | 709 | 2.5e-03 | 1.000 | 5 | GO:0030194 | BP | positive regulation of blood coagulation |
| 1091 | yellow3 | 38 | 2.0e-03 | 1.000 | 2 | GO:0006517 | BP | protein deglycosylation |
| 1092 | yellow3 | 38 | 2.6e-03 | 1.000 | 1 | GO:0043377 | BP | negative regulation of CD8-positive, alpha-beta T cell differentiation |
| 1093 | yellow3 | 38 | 2.6e-03 | 1.000 | 1 | GO:0051141 | BP | negative regulation of NK T cell proliferation |
| 1094 | yellow3 | 38 | 2.6e-03 | 1.000 | 1 | GO:2000640 | BP | positive regulation of SREBP signaling pathway |
| 1095 | yellow3 | 38 | 2.6e-03 | 1.000 | 1 | GO:2000657 | BP | negative regulation of apolipoprotein binding |
| 1096 | yellow3 | 38 | 2.6e-03 | 1.000 | 1 | GO:0005597 | CC | collagen type XVI trimer |
| 1097 | yellow3 | 38 | 2.6e-03 | 1.000 | 1 | GO:0003948 | MF | N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity |
| 1098 | yellow3 | 38 | 2.6e-03 | 1.000 | 1 | GO:0004925 | MF | prolactin receptor activity |
| 1099 | yellow3 | 38 | 2.6e-03 | 1.000 | 1 | GO:0008442 | MF | 3-hydroxyisobutyrate dehydrogenase activity |
| 1100 | yellow3 | 38 | 2.6e-03 | 1.000 | 1 | GO:0033925 | MF | mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity |
| 1101 | yellow4 | 63 | 2.5e-04 | 1.000 | 2 | GO:0019367 | BP | fatty acid elongation, saturated fatty acid |
| 1102 | yellow4 | 63 | 2.5e-04 | 1.000 | 2 | GO:0034625 | BP | fatty acid elongation, monounsaturated fatty acid |
| 1103 | yellow4 | 63 | 2.5e-04 | 1.000 | 2 | GO:0034626 | BP | fatty acid elongation, polyunsaturated fatty acid |
| 1104 | yellow4 | 63 | 2.5e-04 | 1.000 | 2 | GO:0009922 | MF | fatty acid elongase activity |
| 1105 | yellow4 | 63 | 2.5e-04 | 1.000 | 2 | GO:0102336 | MF | 3-oxo-arachidoyl-CoA synthase activity |
| 1106 | yellow4 | 63 | 2.5e-04 | 1.000 | 2 | GO:0102337 | MF | 3-oxo-cerotoyl-CoA synthase activity |
| 1107 | yellow4 | 63 | 2.5e-04 | 1.000 | 2 | GO:0102338 | MF | 3-oxo-lignoceronyl-CoA synthase activity |
| 1108 | yellow4 | 63 | 2.5e-04 | 1.000 | 2 | GO:0102756 | MF | very-long-chain 3-ketoacyl-CoA synthase activity |
| 1109 | yellow4 | 63 | 3.5e-04 | 1.000 | 2 | GO:0030223 | BP | neutrophil differentiation |
| 1110 | yellow4 | 63 | 4.7e-04 | 1.000 | 2 | GO:0004312 | MF | fatty acid synthase activity |
| 1111 | yellowgreen | 97 | 3.1e-04 | 1.000 | 7 | GO:0003714 | MF | transcription corepressor activity |
| 1112 | yellowgreen | 97 | 4.3e-04 | 1.000 | 10 | GO:1902532 | BP | negative regulation of intracellular signal transduction |
| 1113 | yellowgreen | 97 | 9.6e-04 | 1.000 | 3 | GO:0060421 | BP | positive regulation of heart growth |
| 1114 | yellowgreen | 97 | 1.0e-03 | 1.000 | 10 | GO:0003712 | MF | transcription coregulator activity |
| 1115 | yellowgreen | 97 | 1.2e-03 | 1.000 | 4 | GO:0017053 | CC | transcriptional repressor complex |
| 1116 | yellowgreen | 97 | 1.2e-03 | 1.000 | 15 | GO:0045892 | BP | negative regulation of transcription, DNA-templated |
| 1117 | yellowgreen | 97 | 1.4e-03 | 1.000 | 13 | GO:0044212 | MF | transcription regulatory region DNA binding |
| 1118 | yellowgreen | 97 | 1.5e-03 | 1.000 | 3 | GO:0021983 | BP | pituitary gland development |
| 1119 | yellowgreen | 97 | 1.8e-03 | 1.000 | 2 | GO:0002903 | BP | negative regulation of B cell apoptotic process |
| 1120 | yellowgreen | 97 | 1.9e-03 | 1.000 | 15 | GO:1903507 | BP | negative regulation of nucleic acid-templated transcription |
Xarxa cytoscape
